Randi Jenssen Hagerman

Title(s)Professor, Pediatrics
SchoolSchool of Medicine
AddressMIND Bldg/UCDMC
CA 95817
Phone916-703-0247
ORCID ORCID Icon0000-0001-5029-8448 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford Medical School, Stanford CalifMD1975Medicine

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Adaptive, behavioral, and cognitive outcomes in individuals with fragile X syndrome with varying autism severity. Int J Dev Neurosci. 2023 Sep 19. Aishworiya R, Tak YE, Ponzini MD, Biag HMB, Salcedo-Arellano MJ, Kim K, Tassone F, Schneider A, Thurman AJ, Abbeduto L, Hessl D, Randol JL, Bolduc FV, Lippe S, Hagerman P, Hagerman R. PMID: 37724826.
      View in: PubMed   Mentions:
    2. A Longitudinal Study of Executive Function in Daily Life in Male Fragile X Premutation Carriers and Association with FXTAS Conversion. medRxiv. 2023 Sep 02. Hessl D, Rojas KM, Ferrer E, Espinal G, Famula J, Schneider A, Hagerman R, Tassone F, Rivera SM. PMID: 37693384; PMCID: PMC10491369.
      View in: PubMed   Mentions:
    3. Effects of AFQ056 on language learning in fragile X syndrome. J Clin Invest. 2023 Aug 31. Berry-Kravis E, Abbeduto L, Hagerman R, Coffey CS, Cudkowicz M, Erickson CA, McDuffie A, Hessl D, Ethridge LE, Tassone F, Kaufmann WE, Friedmann K, Bullard L, Hoffmann A, Veenstra-VanderWeele J, Staley K, Klements D, Moshinsky M, Harkey B, Long JD, Fedler J, Klingner E, Ecklund DJ, Costigan M, Huff T, Pearson B. PMID: 37651202.
      View in: PubMed   Mentions:
    4. Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTAS. Int J Mol Sci. 2023 Aug 30; 24(17). Zafarullah M, Li J, Salemi MR, Phinney BS, Durbin-Johnson BP, Hagerman R, Hessl D, Rivera SM, Tassone F. PMID: 37686279; PMCID: PMC10488017.
      View in: PubMed   Mentions:
    5. Brain Metabolomics in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS). Cells. 2023 08 23; 12(17). Salcedo-Arellano MJ, Johnson MD, McLennan YA, Hwang YH, Juarez P, McBride EL, Pantoja AP, Durbin-Johnson B, Tassone F, Hagerman RJ, Martínez-Cerdeño V. PMID: 37681866; PMCID: PMC10487256.
      View in: PubMed   Mentions:
    6. Fragile X Syndrome and Fetal Alcohol Syndrome: Occurrence of Dual Diagnosis in a Set of Triplets. J Dev Behav Pediatr. 2023 09 01; 44(7):e470-e475. Aishworiya R, Biag HMB, Salcedo-Arellano MJ, Musa Z, Schneider A, Clark C, Santos E, Tassone F, Hagerman R. PMID: 37556593.
      View in: PubMed   Mentions:
    7. Usefulness of automated image analysis for recognition of the fragile X syndrome gestalt in Congolese subjects. Eur J Med Genet. 2023 Sep; 66(9):104819. Lubala TK, Kayembe-Kitenge T, Mubungu G, Lumaka A, Kanteng G, Savage S, Luboya O, Hagerman R, Devriendt K, Lukusa-Tshilobo P. PMID: 37532084.
      View in: PubMed   Mentions:
    8. Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome. Cells. 2023 07 24; 12(14). Aishworiya R, Chi MH, Zafarullah M, Mendoza G, Ponzini MD, Kim K, Biag HMB, Thurman AJ, Abbeduto L, Hessl D, Randol JL, Bolduc FV, Jacquemont S, Lippé S, Hagerman P, Hagerman R, Schneider A, Tassone F. PMID: 37508583; PMCID: PMC10377864.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. A Postmortem MRI Study of Cerebrovascular Disease and Iron Content at End-Stage of Fragile X-Associated Tremor/Ataxia Syndrome. Cells. 2023 07 20; 12(14). Wang JY, Sonico GJ, Salcedo-Arellano MJ, Hagerman RJ, Martinez-Cerdeno V. PMID: 37508562; PMCID: PMC10377990.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Excitatory neuron-specific suppression of the integrated stress response contributes to autism-related phenotypes in fragile X syndrome. Neuron. 2023 Jul 13. Hooshmandi M, Sharma V, Thörn Perez C, Sood R, Krimbacher K, Wong C, Lister KC, Ureña Guzmán A, Bartley TD, Rocha C, Maussion G, Nadler E, Roque PM, Gantois I, Popic J, Lévesque M, Kaufman RJ, Avoli M, Sanz E, Nader K, Hagerman RJ, Durcan TM, Costa-Mattioli M, Prager-Khoutorsky M, Lacaille JC, Martinez-Cerdeno V, Gibson JR, Huber KM, Sonenberg N, Gkogkas CG, Khoutorsky A. PMID: 37473758.
      View in: PubMed   Mentions:    Fields:    
    11. Activation Ratio Correlates with IQ in Female Carriers of the FMR1 Premutation. Cells. 2023 Jun 24; 12(13). Protic D, Polli R, Hwang YH, Mendoza G, Hagerman R, Durbin-Johnson B, Hayward BE, Usdin K, Murgia A, Tassone F. PMID: 37443745; PMCID: PMC10341054.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    12. Meta-analysis of the Modified Checklist for Autism in Toddlers, Revised/Follow-up for Screening. Pediatrics. 2023 06 01; 151(6). Aishworiya R, Ma VK, Stewart S, Hagerman R, Feldman HM. PMID: 37203373; PMCID: PMC10233738.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    13. Fragile X Syndrome in children. Colomb Med (Cali). 2023 Apr-Jun; 54(2):e4005089. Acero-Garcés DO, Saldarriaga W, Cabal-Herrera AM, Rojas CA, Hagerman RJ. PMID: 37664646; PMCID: PMC10469670.
      View in: PubMed   Mentions:
    14. Clinical implications of somatic allele expansion in female FMR1 premutation carriers. Sci Rep. 2023 04 29; 13(1):7050. Aishworiya R, Hwang YH, Santos E, Hayward B, Usdin K, Durbin-Johnson B, Hagerman R, Tassone F. PMID: 37120588; PMCID: PMC10148869.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    15. The incidence and clinical characteristics of fragile X syndrome in China. Front Pediatr. 2023; 11:1064104. Mei L, Hu C, Li D, Wang Y, Li H, Zhang K, Zhou B, Zhu R, Hagerman RJ, Xu X, Xu Q. PMID: 36861076; PMCID: PMC9969088.
      View in: PubMed   Mentions:
    16. A postmortem MRI study of cerebrovascular disease and iron content at end-stage of fragile X-associated tremor/ataxia syndrome. Res Sq. 2023 Jan 11. Wang JY, Sonico GJ, Salcedo-Arellano MJ, Hagerman RJ, Martínez-Cerdeño V. PMID: 36711694; PMCID: PMC9882645.
      View in: PubMed   Mentions:
    17. Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment. J Neurodev Disord. 2023 01 09; 15(1):1. Palumbo JM, Thomas BF, Budimirovic D, Siegel S, Tassone F, Hagerman R, Faulk C, O'Quinn S, Sebree T. PMID: 36624400; PMCID: PMC9830713.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Targeted Treatments for Fragile X Syndrome. Adv Neurobiol. 2023; 30:225-253. Johnson D, Clark C, Hagerman R. PMID: 36928853.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    19. Drosophila melanogaster as a Model to Study Fragile X-Associated Disorders. Genes (Basel). 2022 12 28; 14(1). Trajkovic J, Makevic V, Pesic M, Pavkovic-Lucic S, Milojevic S, Cvjetkovic S, Hagerman R, Budimirovic DB, Protic D. PMID: 36672829; PMCID: PMC9859539.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    20. Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers. Genes (Basel). 2022 Dec 17; 13(12). Aishworiya R, Protic D, Tang SJ, Schneider A, Tassone F, Hagerman R. PMID: 36553666.
      View in: PubMed   Mentions: 2     Fields:    
    21. Family and Caregiver Characteristics Contribute to Caregiver Change in Use of Strategies and Growth in Child Spoken Language in a Parent-Implemented Language Intervention in Fragile X Syndrome. Perspect ASHA Spec Interest Groups. 2022 Dec; 7(6):1630-1644. Potter SN, Bullard L, Banasik A, Feigles RT, Nguyen V, McDuffie A, Thurman AJ, Hagerman R, Abbeduto L. PMID: 36778100; PMCID: PMC9910303.
      View in: PubMed   Mentions:
    22. Artificial neural network applied to fragile X-associated tremor/ataxia syndrome stage diagnosis based on peripheral mitochondrial bioenergetics and brain imaging outcomes. Sci Rep. 2022 Dec 10; 12(1):21382. Giulivi C, Wang JY, Hagerman RJ. PMID: 36496525.
      View in: PubMed   Mentions: 1     Fields:    
    23. Tophaceous gout of the nose in a male FMR1 premutation carrier. Clin Case Rep. 2022 Nov; 10(11):e6586. Tang SJ, Giri S, Pahlavan N, Han SH, Santos ER, Espinal G, Aishworiya R, Schneider A, Hessl D, Rivera SM, Hagerman RJ. PMID: 36447664; PMCID: PMC9701845.
      View in: PubMed   Mentions:
    24. A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX). J Neurodev Disord. 2022 11 25; 14(1):56. Berry-Kravis E, Hagerman R, Budimirovic D, Erickson C, Heussler H, Tartaglia N, Cohen J, Tassone F, Dobbins T, Merikle E, Sebree T, Tich N, Palumbo JM, O'Quinn S. PMID: 36434514.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    25. The aberrant behavior profile in Indonesian individuals with fragile X syndrome with limited genetic services. Intractable Rare Dis Res. 2022 Nov; 11(4):215-218. Winarni TI, Sumekar TA, Sarjana W, Hardian H, Hagerman RJ, Faradz SM. PMID: 36457587; PMCID: PMC9709619.
      View in: PubMed   Mentions:
    26. Fragile X-associated tremor ataxia syndrome rating scale: Revision and content validity using a mixed method approach. Front Neurol. 2022; 13:977380. Tosin MHS, Stebbins GT, Goetz CG, Hagerman RJ, Hessl D, Zolecki MA, Todd PK, Leehey MA, Hall DA. PMID: 36188408; PMCID: PMC9515309.
      View in: PubMed   Mentions:
    27. Case Reports of Aortic Aneurism in Fragile X Syndrome. Genes (Basel). 2022 08 30; 13(9). Lewis S, DePass A, Hagerman RJ, Lozano R. PMID: 36140728; PMCID: PMC9498845.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Screening for Fragile X Syndrome Among Filipino Children with Autism Spectrum Disorder. J Autism Dev Disord. 2022 Aug 16. Dy ABC, Tanchanco LBS, Sy JCY, Levantino MD, Hagerman RJ. PMID: 35972625.
      View in: PubMed   Mentions:    Fields:    
    29. Fragile X syndrome in a girl with variant Turner syndrome and an isodicentric X chromosome. BMJ Case Rep. 2022 Jul 26; 15(7). Tassanakijpanich N, Wright R, Tassone F, Shankar SP, Hagerman R. PMID: 35882436; PMCID: PMC9330300.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    30. Descriptive analysis of seizures and comorbidities associated with fragile X syndrome. Mol Genet Genomic Med. 2022 08; 10(8):e2001. Albizua I, Charen K, Shubeck L, Talboy A, Berry-Kravis E, Kaufmann WE, Stallworth JL, Drazba KT, Erickson CA, Sweeney JA, Tartaglia N, Warren SF, Hagerman R, Sherman SL, Warren ST, Jin P, Allen EG. PMID: 35852003; PMCID: PMC9356544.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Maturation Delay of Human GABAergic Neurogenesis in Fragile X Syndrome Pluripotent Stem Cells. Stem Cells Transl Med. 2022 06 22; 11(6):613-629. Zhang A, Sokolova I, Domissy A, Davis J, Rao L, Hana Utami K, Wang Y, Hagerman RJ, Pouladi MA, Sanna P, Boland MJ, Loring JF. PMID: 35556144; PMCID: PMC9216490.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    32. Autism spectrum disorder in the fragile X premutation state: possible mechanisms and implications. J Neurol. 2022 Sep; 269(9):4676-4683. Aishworiya R, Protic D, Hagerman R. PMID: 35723724.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    33. Prosaccade and Antisaccade Behavior in Fragile X-Associated Tremor/Ataxia Syndrome Progression. Mov Disord Clin Pract. 2022 May; 9(4):473-478. McLennan YA, Mosconi MW, McKenzie FJ, Famula J, Krawchuk B, Kim K, Clark CJ, Hessl D, Rivera SM, Simon TJ, Tassone F, Hagerman RJ. PMID: 35586536; PMCID: PMC9092736.
      View in: PubMed   Mentions:
    34. Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome. J Neurodev Disord. 2022 03 23; 14(1):23. Famula J, Ferrer E, Hagerman RJ, Tassone F, Schneider A, Rivera SM, Hessl D. PMID: 35321639; PMCID: PMC8942145.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    35. Corrigendum: EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome. Front Psychiatry. 2022; 13:867000. Proteau-Lemieux M, Knoth IS, Agbogba K, Côté V, Barlahan Biag HM, Thurman AJ, Martin CO, Bélanger AM, Rosenfelt C, Tassone F, Abbeduto LJ, Jacquemont S, Hagerman R, Bolduc F, Hessl D, Schneider A, Lippé S. PMID: 35280176; PMCID: PMC8908967.
      View in: PubMed   Mentions: 1  
    36. Fragile X Syndrome: From Molecular Aspect to Clinical Treatment. Int J Mol Sci. 2022 Feb 09; 23(4). Protic DD, Aishworiya R, Salcedo-Arellano MJ, Tang SJ, Milisavljevic J, Mitrovic F, Hagerman RJ, Budimirovic DB. PMID: 35216055; PMCID: PMC8875233.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    37. Clinical and Molecular Correlates of Abnormal Changes in the Cerebellum and Globus Pallidus in Fragile X Premutation. Front Neurol. 2022; 13:797649. Wang JY, Grigsby J, Placido D, Wei H, Tassone F, Kim K, Hessl D, Rivera SM, Hagerman RJ. PMID: 35211082; PMCID: PMC8863211.
      View in: PubMed   Mentions: 3  
    38. Increased Pain Symptomatology Among Females vs. Males With Fragile X-Associated Tremor/Ataxia Syndrome. Front Psychiatry. 2021; 12:762915. Johnson D, Santos E, Kim K, Ponzini MD, McLennan YA, Schneider A, Tassone F, Hagerman RJ. PMID: 35126193; PMCID: PMC8811376.
      View in: PubMed   Mentions: 3  
    39. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder. Neurotherapeutics. 2022 01; 19(1):248-262. Aishworiya R, Valica T, Hagerman R, Restrepo B. PMID: 35029811; PMCID: PMC9130393.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    40. Raising Knowledge and Awareness of Fragile X Syndrome in Serbia, Georgia, and Colombia: A Model for Other Developing Countries? Yale J Biol Med. 2021 12; 94(4):559-571. Protic D, Salcedo-Arellano MJ, Stojkovic M, Saldarriaga W, Ávila Vidal LA, Miller RM, Tabatadze N, Peric M, Hagerman R, Budimirovic DB. PMID: 34970093; PMCID: PMC8686783.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. Fragile X Premutation: Medications, Therapy and Lifestyle Advice. Pharmgenomics Pers Med. 2021; 14:1689-1699. Sodhi DK, Hagerman R. PMID: 35002287; PMCID: PMC8721286.
      View in: PubMed   Mentions: 6  
    42. Recent research in fragile X-associated tremor/ataxia syndrome. Curr Opin Neurobiol. 2022 02; 72:155-159. Salcedo-Arellano MJ, Hagerman RJ. PMID: 34890957.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    43. Eye Movements in Fragile X-Associated Tremor/Ataxia Syndrome. J Neuroophthalmol. 2021 12 01; 41(4):e661-e664. Hall DA, Leehey MA, Hagerman RJ, Pelak VS. PMID: 33110011.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome. Front Psychiatry. 2021; 12:716707. Proteau-Lemieux M, Knoth IS, Agbogba K, Côté V, Barlahan Biag HM, Thurman AJ, Martin CO, Bélanger AM, Rosenfelt C, Tassone F, Abbeduto LJ, Jacquemont S, Hagerman R, Bolduc F, Hessl D, Schneider A, Lippé S. PMID: 34858220; PMCID: PMC8632368.
      View in: PubMed   Mentions: 3  
    45. FMRP Levels in Human Peripheral Blood Leukocytes Correlates with Intellectual Disability. Diagnostics (Basel). 2021 Sep 28; 11(10). Roth M, Ronco L, Cadavid D, Durbin-Johnson B, Hagerman RJ, Tassone F. PMID: 34679478; PMCID: PMC8534530.
      View in: PubMed   Mentions: 3  
    46. Case Report: Coexistence of Alzheimer-Type Neuropathology in Fragile X-Associated Tremor Ataxia Syndrome. Front Neurosci. 2021; 15:720253. Salcedo-Arellano MJ, Sanchez D, Wang JY, McLennan YA, Clark CJ, Juarez P, Schneider A, Tassone F, Hagerman RJ, Martínez-Cerdeño V. PMID: 34602969; PMCID: PMC8485779.
      View in: PubMed   Mentions: 4  
    47. Hispano-American Brain Bank on Neurodevelopmental Disorders: An initiative to promote brain banking, research, education, and outreach in the field of neurodevelopmental disorders. Brain Pathol. 2022 03; 32(2):e13019. Dufour BD, Albores-Gallo L, Luna-Muñoz J, Hagerman R, Miquelajauregui A, Buriticá E, Saldarriaga W, Pacheco-Herrero M, Yris Silvestre-Sosa A, Mazefsky C, Gastgeb H, Kofler J, Casanova M, Hof PR, London E, Hagerman P, Martínez-Cerdeño V. PMID: 34515386; PMCID: PMC8877728.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. Fragile X Syndrome: Lessons Learned and What New Treatment Avenues Are on the Horizon. Annu Rev Pharmacol Toxicol. 2022 01 06; 62:365-381. Hagerman RJ, Hagerman PJ. PMID: 34499526.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. Brain Atrophy and White Matter Damage Linked to Peripheral Bioenergetic Deficits in the Neurodegenerative Disease FXTAS. Int J Mol Sci. 2021 Aug 25; 22(17). Wang J, Napoli E, Kim K, McLennan YA, Hagerman RJ, Giulivi C. PMID: 34502080; PMCID: PMC8431233.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    50. Fragile X-associated tremor/ataxia syndrome: pathophysiology and management. Curr Opin Neurol. 2021 08 01; 34(4):541-546. Hagerman R, Hagerman P. PMID: 33990099; PMCID: PMC8412174.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    51. Hypermobile Ehlers-Danlos syndrome (hEDS) phenotype in fragile X premutation carriers: case series. J Med Genet. 2022 07; 59(7):687-690. Tassanakijpanich N, McKenzie FJ, McLennan YA, Makhoul E, Tassone F, Jasoliya MJ, Romney C, Petrasic IC, Napalinga K, Buchanan CB, Hagerman P, Hagerman R, Casanova EL. PMID: 34193467; PMCID: PMC8717836.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    52. Sulforaphane improves mitochondrial metabolism in fibroblasts from patients with fragile X-associated tremor and ataxia syndrome. Neurobiol Dis. 2021 09; 157:105427. Napoli E, Flores A, Mansuri Y, Hagerman RJ, Giulivi C. PMID: 34153466; PMCID: PMC8475276.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    53. Deficits in Prenatal Serine Biosynthesis Underlie the Mitochondrial Dysfunction Associated with the Autism-Linked FMR1 Gene. Int J Mol Sci. 2021 May 30; 22(11). Nolin SL, Napoli E, Flores A, Hagerman RJ, Giulivi C. PMID: 34070950; PMCID: PMC8198117.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    54. Corrigendum: Human Cerebral Cortex Proteome of Fragile X-Associated Tremor/Ataxia Syndrome. Front Mol Biosci. 2021; 8:695407. Holm KN, Herren AW, Taylor SL, Randol JL, Kim K, Espinal G, Martínez-Cerdeño V, Pessah IN, Hagerman RJ, Hagerman PJ. PMID: 34055898; PMCID: PMC8152804.
      View in: PubMed   Mentions:
    55. Cerebral Microbleeds in Fragile X-Associated Tremor/Ataxia Syndrome. Mov Disord. 2021 08; 36(8):1935-1943. Salcedo-Arellano MJ, Wang JY, McLennan YA, Doan M, Cabal-Herrera AM, Jimenez S, Wolf-Ochoa MW, Sanchez D, Juarez P, Tassone F, Durbin-Johnson B, Hagerman RJ, Martínez-Cerdeño V. PMID: 33760253.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    56. Fragile X syndrome. Curr Biol. 2021 03 22; 31(6):R273-R275. Hagerman PJ, Hagerman R. PMID: 33756134.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    57. Inequities in diagnosis of Fragile X syndrome in Colombia. J Appl Res Intellect Disabil. 2021 May; 34(3):830-839. Saldarriaga-Gil W, Cabal-Herrera AM, Fandiño-Losada A, Vásquez A, Hagerman R, Tassone F. PMID: 33538083.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    58. Surveillance and prevalence of fragile X syndrome in Indonesia. Intractable Rare Dis Res. 2021 Feb; 10(1):11-16. Sihombing NRB, Winarni TI, Utari A, van Bokhoven H, Hagerman RJ, Faradz SM. PMID: 33614370; PMCID: PMC7882090.
      View in: PubMed   Mentions: 3  
    59. Human Cerebral Cortex Proteome of Fragile X-Associated Tremor/Ataxia Syndrome. Front Mol Biosci. 2020; 7:600840. Holm KN, Herren AW, Taylor SL, Randol JL, Kim K, Espinal G, Martiínez-Cerdeño V, Pessah IN, Hagerman RJ, Hagerman PJ. PMID: 33585555; PMCID: PMC7879451.
      View in: PubMed   Mentions: 4  
    60. Fragile X premutation and associated health conditions: A review. Clin Genet. 2021 06; 99(6):751-760. Tassanakijpanich N, Hagerman RJ, Worachotekamjorn J. PMID: 33443313.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    61. Double Genetic Hit: Fragile X Syndrome and Partial Deletion of Protein Patched Homolog 1 Antisense as Cause of Severe Autism Spectrum Disorder. J Dev Behav Pediatr. 2020 12; 41(9):724-728. Saldarriaga W, Payán-Gómez C, González-Teshima LY, Rosa L, Tassone F, Hagerman RJ. PMID: 32947579.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    62. Overlapping Molecular Pathways Leading to Autism Spectrum Disorders, Fragile X Syndrome, and Targeted Treatments. Neurotherapeutics. 2021 01; 18(1):265-283. Salcedo-Arellano MJ, Cabal-Herrera AM, Punatar RH, Clark CJ, Romney CA, Hagerman RJ. PMID: 33215285; PMCID: PMC8116395.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    63. Review of Autism Profiles and Response to Sertraline in Fragile X Syndrome-Associated Autism vs. Non-syndromic Autism; Next Steps for Targeted Treatment. Front Neurol. 2020; 11:581429. Rajaratnam A, Potter LA, Biag HMB, Schneider A, Petrasic IC, Hagerman RJ. PMID: 33193037; PMCID: PMC7661746.
      View in: PubMed   Mentions: 5  
    64. Characterization of the Metabolic, Clinical and Neuropsychological Phenotype of Female Carriers of the Premutation in the X-Linked FMR1 Gene. Front Mol Biosci. 2020; 7:578640. Napoli E, McLennan YA, Schneider A, Tassone F, Hagerman RJ, Giulivi C. PMID: 33195422; PMCID: PMC7642626.
      View in: PubMed   Mentions: 8  
    65. Cardiovascular Problems in the Fragile X Premutation. Front Genet. 2020; 11:586910. Tassanakijpanich N, Cohen J, Cohen R, Srivatsa UN, Hagerman RJ. PMID: 33133171; PMCID: PMC7578382.
      View in: PubMed   Mentions: 4  
    66. Cortical gyrification and its relationships with molecular measures and cognition in children with the FMR1 premutation. Sci Rep. 2020 09 29; 10(1):16059. Wang JY, Danial M, Soleymanzadeh C, Kim B, Xia Y, Kim K, Tassone F, Hagerman RJ, Rivera SM. PMID: 32994518; PMCID: PMC7525519.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    67. Women with Fragile X-associated Tremor/Ataxia Syndrome. Mov Disord Clin Pract. 2020 Nov; 7(8):910-919. Schneider A, Summers S, Tassone F, Seritan A, Hessl D, Hagerman P, Hagerman R. PMID: 33163562; PMCID: PMC7604678.
      View in: PubMed   Mentions: 8  
    68. Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis. Brain Sci. 2020 Sep 11; 10(9). Luu S, Province H, Berry-Kravis E, Hagerman R, Hessl D, Vaidya D, Lozano R, Rosselot H, Erickson C, Kaufmann WE, Budimirovic DB. PMID: 32932789; PMCID: PMC7563217.
      View in: PubMed   Mentions: 12  
    69. Cerebellar-cortical function and connectivity during sensorimotor behavior in aging FMR1 gene premutation carriers. Neuroimage Clin. 2020; 27:102332. McKinney WS, Bartolotti J, Khemani P, Wang JY, Hagerman RJ, Mosconi MW. PMID: 32711390; PMCID: PMC7381687.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    70. Elevated FMR1-mRNA and lowered FMRP - A double-hit mechanism for psychiatric features in men with FMR1 premutations. Transl Psychiatry. 2020 06 23; 10(1):205. Schneider A, Winarni TI, Cabal-Herrera AM, Bacalman S, Gane L, Hagerman P, Tassone F, Hagerman R. PMID: 32576818; PMCID: PMC7311546.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    71. Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications. Int J Mol Sci. 2020 Jun 20; 21(12). Cabal-Herrera AM, Tassanakijpanich N, Salcedo-Arellano MJ, Hagerman RJ. PMID: 32575683; PMCID: PMC7352421.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    72. Blood-Based Biomarkers Predictive of Metformin Target Engagement in Fragile X Syndrome. Brain Sci. 2020 Jun 10; 10(6). Jasoliya M, Bowling H, Petrasic IC, Durbin-Johnson B, Klann E, Bhattacharya A, Hagerman R, Tassone F. PMID: 32531912; PMCID: PMC7349631.
      View in: PubMed   Mentions: 2  
    73. Ataxia as the Major Manifestation of Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Case Series. Biomedicines. 2020 May 25; 8(5). Salcedo-Arellano MJ, Cabal-Herrera AM, Tassanakijpanich N, McLennan YA, Hagerman RJ. PMID: 32466255; PMCID: PMC7277845.
      View in: PubMed   Mentions: 5  
    74. A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome. Pediatr Neurol. 2020 09; 110:30-41. Berry-Kravis E, Horrigan JP, Tartaglia N, Hagerman R, Kolevzon A, Erickson CA, Hatti S, Snape M, Yaroshinsky A, Stoms G, FXS-001 Investigators, Glass L, Jones NE. PMID: 32660869.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    75. Fragile X associated neuropsychiatric disorders in a male without FXTAS. Intractable Rare Dis Res. 2020 May; 9(2):113-118. Cabal-Herrera AM, Saldarriaga-Gil W, Salcedo-Arellano MJ, Hagerman RJ. PMID: 32494560; PMCID: PMC7263992.
      View in: PubMed   Mentions: 4  
    76. Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome. J Neurodev Disord. 2020 04 22; 12(1):12. Thurman AJ, Potter LA, Kim K, Tassone F, Banasik A, Potter SN, Bullard L, Nguyen V, McDuffie A, Hagerman R, Abbeduto L. PMID: 32316911; PMCID: PMC7175541.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    77. Molecular Biomarkers Predictive of Sertraline Treatment Response in Young Children With Autism Spectrum Disorder. Front Genet. 2020; 11:308. Alolaby RR, Jiraanont P, Durbin-Johnson B, Jasoliya M, Tang HT, Hagerman R, Tassone F. PMID: 32346385; PMCID: PMC7174723.
      View in: PubMed   Mentions:
    78. Editorial: Secondary vs. Idiopathic Autism. Front Psychiatry. 2020; 11:297. Casanova MF, Casanova EL, Frye RE, Baeza-Velasco C, LaSalle JM, Hagerman RJ, Scherer SW, Natowicz MR. PMID: 32346372; PMCID: PMC7171716.
      View in: PubMed   Mentions: 10  
    79. Parkinsonism Versus Concomitant Parkinson's Disease in Fragile X-Associated Tremor/Ataxia Syndrome. Mov Disord Clin Pract. 2020 May; 7(4):413-418. Salcedo-Arellano MJ, Wolf-Ochoa MW, Hong T, Amina S, Tassone F, Lechpammer M, Hagerman R, Martínez-Cerdeño V. PMID: 32373658; PMCID: PMC7197312.
      View in: PubMed   Mentions: 7  
    80. Placebo Response in Fragile X-associated Tremor/Ataxia Syndrome. Mov Disord Clin Pract. 2020 Apr; 7(3):298-302. Hill EJ, Goetz CG, Stebbins GT, Hagerman R, Ouyang B, Hall DA. PMID: 32258228; PMCID: PMC7111569.
      View in: PubMed   Mentions:
    81. Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer's Disease. Clin Interv Aging. 2020; 15:285-292. Aydin EY, Schneider A, Protic D, Wang JY, Martínez-Cerdeño V, Tassone F, Tang HT, Perlman S, Hagerman RJ. PMID: 32161452; PMCID: PMC7051898.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    82. Spontaneous Coronary Artery Dissection in Females With the Fragile X FMR1 Premutation. JACC Case Rep. 2020 Jan; 2(1):40-44. McKenzie FJ, Tassankijpanich N, Epps KC, March SK, Hagerman RJ. PMID: 32154514; PMCID: PMC7062363.
      View in: PubMed   Mentions: 6  
    83. Fragile X syndrome and associated disorders: Clinical aspects and pathology. Neurobiol Dis. 2020 03; 136:104740. Salcedo-Arellano MJ, Dufour B, McLennan Y, Martinez-Cerdeno V, Hagerman R. PMID: 31927143; PMCID: PMC7027994.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimals
    84. Developmental aspects of FXAND in a man with the FMR1 premutation. Mol Genet Genomic Med. 2020 02; 8(2):e1050. Santos E, Emeka-Nwonovo C, Wang JY, Schneider A, Tassone F, Hagerman P, Hagerman R. PMID: 31899609; PMCID: PMC7005639.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    85. Fragile X syndrome: clinical presentation, pathology and treatment. Gac Med Mex. 2020; 156(1):60-66. Salcedo-Arellano MJ, Hagerman RJ, Martínez-Cerdeño V. PMID: 32026885.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    86. Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions. PLoS One. 2019; 14(12):e0226811. Kim K, Hessl D, Randol JL, Espinal GM, Schneider A, Protic D, Aydin EY, Hagerman RJ, Hagerman PJ. PMID: 31891607; PMCID: PMC6938341.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    87. A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder. Front Psychiatry. 2019; 10:810. Potter LA, Scholze DA, Biag HMB, Schneider A, Chen Y, Nguyen DV, Rajaratnam A, Rivera SM, Dwyer PS, Tassone F, Al Olaby RR, Choudhary NS, Salcedo-Arellano MJ, Hagerman RJ. PMID: 31780970; PMCID: PMC6851992.
      View in: PubMed   Mentions: 11  
    88. Interaction between ventricular expansion and structural changes in the corpus callosum and putamen in males with FMR1 normal and premutation alleles. Neurobiol Aging. 2020 02; 86:27-38. Wang JY, Hessl D, Tassone F, Kim K, Hagerman RJ, Rivera SM. PMID: 31733943; PMCID: PMC6995416.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    89. Metformin treatment in young children with fragile X syndrome. Mol Genet Genomic Med. 2019 11; 7(11):e956. Biag HMB, Potter LA, Wilkins V, Afzal S, Rosvall A, Salcedo-Arellano MJ, Rajaratnam A, Manzano-Nunez R, Schneider A, Tassone F, Rivera SM, Hagerman RJ. PMID: 31520524; PMCID: PMC6825840.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    90. Composition of the Intranuclear Inclusions of Fragile X-associated Tremor/Ataxia Syndrome. Acta Neuropathol Commun. 2019 09 03; 7(1):143. Ma L, Herren AW, Espinal G, Randol J, McLaughlin B, Martinez-Cerdeño V, Pessah IN, Hagerman RJ, Hagerman PJ. PMID: 31481131; PMCID: PMC6720097.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    91. General Anesthetic Use in Fragile X Spectrum Disorders. J Neurosurg Anesthesiol. 2019 Jul; 31(3):285-290. Ligsay A, El-Deeb M, Salcedo-Arellano MJ, Schloemerkemper N, Grayson JS, Hagerman R. PMID: 29734272; PMCID: PMC6215737.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    92. EEG Abnormalities as a Neurophysiological Biomarker of Severity in Autism Spectrum Disorder: A Pilot Cohort Study. J Autism Dev Disord. 2019 Jun; 49(6):2337-2347. Nicotera AG, Hagerman RJ, Catania MV, Buono S, Di Nuovo S, Liprino EM, Stracuzzi E, Giusto S, Di Vita G, Musumeci SA. PMID: 30726535.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    93. Fragile X- associated Neuropsychiatric Disorders: A Case Report. Future Neurol. 2019 May; 14(2). Tan MM, Dy JB, Salcedo-Arellano MJ, Tassone F, Hagerman RJ. PMID: 32089651; PMCID: PMC7034938.
      View in: PubMed   Mentions: 3  
    94. Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin-two cases. Mol Genet Genomic Med. 2019 07; 7(7):e00745. Protic D, Aydin EY, Tassone F, Tan MM, Hagerman RJ, Schneider A. PMID: 31104364; PMCID: PMC6625129.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    95. De novo and biallelic DEAF1 variants cause a phenotypic spectrum. Genet Med. 2019 09; 21(9):2059-2069. Nabais Sá MJ, Jensik PJ, McGee SR, Parker MJ, Lahiri N, McNeil EP, Kroes HY, Hagerman RJ, Harrison RE, Montgomery T, Splitt M, Palmer EE, Sachdev RK, Mefford HC, Scott AA, Martinez-Agosto JA, Lorenz R, Orenstein N, Berg JN, Amiel J, Heron D, Keren B, Cobben JM, Menke LA, Marco EJ, Graham JM, Pierson TM, Karimiani EG, Maroofian R, Manzini MC, Cauley ES, Colombo R, Odent S, Dubourg C, Phornphutkul C, de Brouwer APM, de Vries BBA, Vulto-vanSilfhout AT. PMID: 30923367.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    96. Turning the tide on targeted treatments for neurodevelopmental disorders. Neurology. 2019 04 16; 92(16):741-742. Hagerman R, Tuchman R. PMID: 30918096.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    97. Consensus Statement of the Indian Academy of Pediatrics on Diagnosis and Management of Fragile X Syndrome in India. Indian Pediatr. 2019 03 15; 56(3):221-228. Sachdeva A, Jain P, Gunasekaran V, Mahay SB, Mukherjee S, Hagerman R, Shankar S, Kapoor S, Kedia SN, Indian Academy of Pediatrics Consensus in Diagnosis and Management of Fragile X Syndrome Committee., Indian Academy of Pediatrics Consensus in Diagnosis and Management of Fragile X Syndrome Committee. PMID: 30954995.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    98. Treatment of Fragile X Syndrome with Cannabidiol: A Case Series Study and Brief Review of the Literature. Cannabis Cannabinoid Res. 2019; 4(1):3-9. Tartaglia N, Bonn-Miller M, Hagerman R. PMID: 30944868; PMCID: PMC6446166.
      View in: PubMed   Mentions: 18     Fields:    
    99. [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment]. Rev Neurol. 2019 Mar 01; 68(5):199-206. Salcedo-Arellano MJ, Hagerman RJ, Martinez-Cerdeno V. PMID: 30805918; PMCID: PMC7001878.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    100. Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale. Mov Disord Clin Pract. 2019 Feb; 6(2):120-124. Hall DA, Stebbins GT, Jacquemont S, Berry-Kravis E, Goetz CG, Hagerman R, Zhang L, Leehey MA. PMID: 30838310; PMCID: PMC6384171.
      View in: PubMed   Mentions: 9  
    101. Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in Fragile X Syndrome. PLoS One. 2019; 14(1):e0209984. Hessl D, Harvey D, Sansone S, Crestodina C, Chin J, Joshi R, Hagerman RJ, Berry-Kravis E. PMID: 30653533; PMCID: PMC6336311.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    102. New Targeted Treatments for Fragile X Syndrome. Curr Pediatr Rev. 2019; 15(4):251-258. Protic D, Salcedo-Arellano MJ, Dy JB, Potter LA, Hagerman RJ. PMID: 31241016; PMCID: PMC6930353.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    103. Widespread RNA editing dysregulation in brains from autistic individuals. Nat Neurosci. 2019 01; 22(1):25-36. Tran SS, Jun HI, Bahn JH, Azghadi A, Ramaswami G, Van Nostrand EL, Nguyen TB, Hsiao YE, Lee C, Pratt GA, Martínez-Cerdeño V, Hagerman RJ, Yeo GW, Geschwind DH, Xiao X. PMID: 30559470; PMCID: PMC6375307.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCells
    104. Best Practices in Fragile X Syndrome Treatment Development. Brain Sci. 2018 Dec 15; 8(12). Erickson CA, Kaufmann WE, Budimirovic DB, Lachiewicz A, Haas-Givler B, Miller RM, Weber JD, Abbeduto L, Hessl D, Hagerman RJ, Berry-Kravis E. PMID: 30558274; PMCID: PMC6315698.
      View in: PubMed   Mentions: 20  
    105. Microglial cell activation and senescence are characteristic of the pathology FXTAS. Mov Disord. 2018 12; 33(12):1887-1894. Martínez Cerdeño V, Hong T, Amina S, Lechpammer M, Ariza J, Tassone F, Noctor SC, Hagerman P, Hagerman R. PMID: 30537011; PMCID: PMC6413690.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    106. Fragile X syndrome and connective tissue dysregulation. Clin Genet. 2019 02; 95(2):262-267. Ramírez-Cheyne JA, Duque GA, Ayala-Zapata S, Saldarriaga-Gil W, Hagerman P, Hagerman R, Payán-Gómez C. PMID: 30414172.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    107. Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents. Sci Rep. 2018 11 19; 8(1):16970. Hagerman R, Jacquemont S, Berry-Kravis E, Des Portes V, Stanfield A, Koumaras B, Rosenkranz G, Murgia A, Wolf C, Apostol G, von Raison F. PMID: 30451888; PMCID: PMC6242849.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    108. Fragile X-Associated Neuropsychiatric Disorders (FXAND). Front Psychiatry. 2018; 9:564. Hagerman RJ, Protic D, Rajaratnam A, Salcedo-Arellano MJ, Aydin EY, Schneider A. PMID: 30483160; PMCID: PMC6243096.
      View in: PubMed   Mentions: 88  
    109. Protein synthesis levels are increased in a subset of individuals with fragile X syndrome. Hum Mol Genet. 2018 11 01; 27(21):3825. Jacquemont S, Pacini L, Jønch AE, Cencelli G, Rozenberg I, He Y, D'Andrea L, Pedini G, Eldeeb M, Willemsen R, Gasparini F, Tassone F, Hagerman R, Gomez-Mancilla B, Bagni C. PMID: 30107584; PMCID: PMC6196653.
      View in: PubMed   Mentions: 11     Fields:    
    110. Increased severity of fragile X spectrum disorders in the agricultural community of Ricaurte, Colombia. Int J Dev Neurosci. 2019 Feb; 72:1-5. Saldarriaga W, Salcedo-Arellano MJ, Rodriguez-Guerrero T, Ríos M, Fandiño-Losada A, Ramirez-Cheyne J, Lein PJ, Tassone F, Hagerman RJ. PMID: 30385191; PMCID: PMC6354926.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    111. Cognitive Deficits and Associated ERP N400 Abnormalities in FXTAS With Parkinsonism. Front Genet. 2018; 9:327. Wang XH, Yang JC, Soohoo R, Cotter D, Yuan M, Xia J, Yaqub S, Doty J, Niu YQ, Tassone F, Hagerman R, Zhang L, Olichney J. PMID: 30279697; PMCID: PMC6153313.
      View in: PubMed   Mentions:
    112. Allopregnanolone Treatment Improves Plasma Metabolomic Profile Associated with GABA Metabolism in Fragile X-Associated Tremor/Ataxia Syndrome: a Pilot Study. Mol Neurobiol. 2019 May; 56(5):3702-3713. Napoli E, Schneider A, Wang JY, Trivedi A, Carrillo NR, Tassone F, Rogawski M, Hagerman RJ, Giulivi C. PMID: 30187385; PMCID: PMC6401336.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    113. Impact of FMR1 Premutation on Neurobehavior and Bioenergetics in Young Monozygotic Twins. Front Genet. 2018; 9:338. Napoli E, Schneider A, Hagerman R, Song G, Wong S, Tassone F, Giulivi C. PMID: 30210529; PMCID: PMC6119880.
      View in: PubMed   Mentions: 11  
    114. Presence of Middle Cerebellar Peduncle Sign in FMR1 Premutation Carriers Without Tremor and Ataxia. Front Neurol. 2018; 9:695. Famula JL, McKenzie F, McLennan YA, Grigsby J, Tassone F, Hessl D, Rivera SM, Martinez-Cerdeno V, Hagerman RJ. PMID: 30186228; PMCID: PMC6113389.
      View in: PubMed   Mentions: 11  
    115. Middle Cerebellar Peduncle Width-A Novel MRI Biomarker for FXTAS? Front Neurosci. 2018; 12:379. Shelton AL, Wang JY, Fourie E, Tassone F, Chen A, Frizzi L, Hagerman RJ, Ferrer E, Hessl D, Rivera SM. PMID: 29988561; PMCID: PMC6026659.
      View in: PubMed   Mentions: 10  
    116. Protein synthesis levels are increased in a subset of individuals with fragile X syndrome. Hum Mol Genet. 2018 06 15; 27(12):2039-2051. Jacquemont S, Pacini L, Jønch AE, Cencelli G, Rozenberg I, He Y, D'Andrea L, Pedini G, Eldeeb M, Willemsen R, Gasparini F, Tassone F, Hagerman R, Gomez-Mancilla B, Bagni C. PMID: 29590342; PMCID: PMC5985734.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    117. Fragile X-Associated Tremor/Ataxia Syndrome: Unmet Needs and a Path for the Future. Front Genet. 2018; 9:100. Hall DA, Hagerman RJ. PMID: 29951081; PMCID: PMC6008554.
      View in: PubMed   Mentions: 2  
    118. Fragile X checklists: A meta-analysis and development of a simplified universal clinical checklist. Mol Genet Genomic Med. 2018 Apr 06. Lubala TK, Lumaka A, Kanteng G, Mutesa L, Mukuku O, Wembonyama S, Hagerman R, Luboya ON, Lukusa Tshilobo P. PMID: 29624914; PMCID: PMC6081230.
      View in: PubMed   Mentions: 8     Fields:    
    119. Fentanyl overdose in a female with the FMR1 premutation and FXTAS. J Mol Genet (Isleworth). 2018 Nov; 1(1). El-Deeb M, Adams P, Schneider A, Salcedo-Arellano MJ, Tassone F, Hagerman R. PMID: 31032490; PMCID: PMC6482838.
      View in: PubMed   Mentions: 3  
    120. Genetic cluster of fragile X syndrome in a Colombian district. J Hum Genet. 2018 Apr; 63(4):509-516. Saldarriaga W, Forero-Forero JV, González-Teshima LY, Fandiño-Losada A, Isaza C, Tovar-Cuevas JR, Silva M, Choudhary NS, Tang HT, Aguilar-Gaxiola S, Hagerman RJ, Tassone F. PMID: 29379191.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsPHPublic Health
    121. Fragile X syndrome and fragile X-associated disorders. F1000Res. 2017; 6:2112. Rajaratnam A, Shergill J, Salcedo-Arellano M, Saldarriaga W, Duan X, Hagerman R. PMID: 29259781; PMCID: PMC5728189.
      View in: PubMed   Mentions: 21     Fields:    
    122. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nat Rev Drug Discov. 2018 04; 17(4):280-299. Berry-Kravis EM, Lindemann L, Jønch AE, Apostol G, Bear MF, Carpenter RL, Crawley JN, Curie A, Des Portes V, Hossain F, Gasparini F, Gomez-Mancilla B, Hessl D, Loth E, Scharf SH, Wang PP, Von Raison F, Hagerman R, Spooren W, Jacquemont S. PMID: 29217836; PMCID: PMC6904225.
      View in: PubMed   Mentions: 138     Fields:    Translation:HumansAnimals
    123. Rare FMR1 gene mutations causing fragile X syndrome: A review. Am J Med Genet A. 2018 01; 176(1):11-18. Sitzmann AF, Hagelstrom RT, Tassone F, Hagerman RJ, Butler MG. PMID: 29178241; PMCID: PMC6697153.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    124. Prenatal Diagnosis of Fragile X: Can a Full Mutation Allele in the FMR1 Gene Contract to a Normal Size? Front Genet. 2017; 8:158. Manor E, Jabareen A, Magal N, Kofman A, Hagerman RJ, Tassone F. PMID: 29163631; PMCID: PMC5675867.
      View in: PubMed   Mentions: 5  
    125. Size and methylation mosaicism in males with Fragile X syndrome. Expert Rev Mol Diagn. 2017 11; 17(11):1023-1032. Jiraanont P, Kumar M, Tang HT, Espinal G, Hagerman PJ, Hagerman RJ, Chutabhakdikul N, Tassone F. PMID: 28929824; PMCID: PMC5924764.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    126. Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome. Neurotherapeutics. 2017 Oct; 14(4):1073-1083. Wang JY, Trivedi AM, Carrillo NR, Yang J, Schneider A, Giulivi C, Adams P, Tassone F, Kim K, Rivera SM, Lubarr N, Wu CY, Irwin RW, Brinton RD, Olichney JM, Rogawski MA, Hagerman RJ. PMID: 28707277; PMCID: PMC5722761.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    127. Fragile X syndrome. Nat Rev Dis Primers. 2017 Sep 29; 3:17065. Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB, Moine H, Kooy RF, Tassone F, Gantois I, Sonenberg N, Mandel JL, Hagerman PJ. PMID: 28960184.
      View in: PubMed   Mentions: 262     Fields:    Translation:Humans
    128. Distance delivery of a spoken language intervention for school-aged and adolescent boys with fragile X syndrome. Dev Neurorehabil. 2018 Jan; 21(1):48-63. McDuffie A, Banasik A, Bullard L, Nelson S, Feigles RT, Hagerman R, Abbeduto L. PMID: 28956679; PMCID: PMC5986725.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    129. Metformin as targeted treatment in fragile X syndrome. Clin Genet. 2018 02; 93(2):216-222. Dy ABC, Tassone F, Eldeeb M, Salcedo-Arellano MJ, Tartaglia N, Hagerman R. PMID: 28436599; PMCID: PMC6944702.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimals
    130. Concomitant occurrence of FXTAS and clinically defined sporadic inclusion body myositis: report of two cases. Croat Med J. 2017 Aug 31; 58(4):310-315. Lechpammer M, Martínez Cerdeno V, Hunsaker MR, Hah M, Gonzales H, Tisch S, Joffe R, Pamphlett R, Tassone F, Hagerman PJ, Bolitho SJ, Hagerman RJ. PMID: 28857524; PMCID: PMC5577649.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    131. Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results. Neuropsychopharmacology. 2018 02; 43(3):503-512. Youssef EA, Berry-Kravis E, Czech C, Hagerman RJ, Hessl D, Wong CY, Rabbia M, Deptula D, John A, Kinch R, Drewitt P, Lindemann L, Marcinowski M, Langland R, Horn C, Fontoura P, Santarelli L, Quiroz JA, FragXis Study Group. PMID: 28816242; PMCID: PMC5770759.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCellsCTClinical Trials
    132. A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome. J Neurodev Disord. 2017 Aug 02; 9(1):26. Ligsay A, Van Dijck A, Nguyen DV, Lozano R, Chen Y, Bickel ES, Hessl D, Schneider A, Angkustsiri K, Tassone F, Ceulemans B, Kooy RF, Hagerman RJ. PMID: 28764646; PMCID: PMC5540519.
      View in: PubMed   Mentions: 30     Fields:    
    133. Children With Fragile X Syndrome Display Threat-Specific Biases Toward Emotion. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 09; 2(6):487-492. Burris JL, Barry-Anwar RA, Sims RN, Hagerman RJ, Tassone F, Rivera SM. PMID: 29348038.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    134. Autism Symptoms in Fragile X Syndrome. J Child Neurol. 2017 Sep; 32(10):903-909. Niu M, Han Y, Dy ABC, Du J, Jin H, Qin J, Zhang J, Li Q, Hagerman RJ. PMID: 28617074.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    135. Arbaclofen in fragile X syndrome: results of phase 3 trials. J Neurodev Disord. 2017; 9:3. Berry-Kravis E, Hagerman R, Visootsak J, Budimirovic D, Kaufmann WE, Cherubini M, Zarevics P, Walton-Bowen K, Wang P, Bear MF, Carpenter RL. PMID: 28616094; PMCID: PMC5467054.
      View in: PubMed   Mentions: 68     Fields:    
    136. Fragile X targeted pharmacotherapy: lessons learned and future directions. J Neurodev Disord. 2017; 9:7. Erickson CA, Davenport MH, Schaefer TL, Wink LK, Pedapati EV, Sweeney JA, Fitzpatrick SE, Brown WT, Budimirovic D, Hagerman RJ, Hessl D, Kaufmann WE, Berry-Kravis E. PMID: 28616096; PMCID: PMC5467059.
      View in: PubMed   Mentions: 61     Fields:    
    137. Fragile X Syndrome: Prevalence, Treatment, and Prevention in China. Front Neurol. 2017; 8:254. Niu M, Han Y, Dy ABC, Du J, Jin H, Qin J, Zhang J, Li Q, Hagerman RJ. PMID: 28634468; PMCID: PMC5459883.
      View in: PubMed   Mentions: 7  
    138. Two FMR1 premutation cases without nuclear inclusions. Mov Disord. 2017 09; 32(9):1328-1329. Martínez-Cerdeño V, Lechpammer M, Hagerman PJ, Hagerman R. PMID: 28568317; PMCID: PMC5714313.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    139. Fragile X Newborn Screening: Lessons Learned From a Multisite Screening Study. Pediatrics. 2017 Jun; 139(Suppl 3):S216-S225. Bailey DB, Berry-Kravis E, Gane LW, Guarda S, Hagerman R, Powell CM, Tassone F, Wheeler A. PMID: 28814542.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsPHPublic Health
    140. Implications of the FMR1 Premutation for Children, Adolescents, Adults, and Their Families. Pediatrics. 2017 Jun; 139(Suppl 3):S172-S182. Wheeler A, Raspa M, Hagerman R, Mailick M, Riley C. PMID: 28814538; PMCID: PMC5621635.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    141. Genetics, white matter, and cognition: The effects of methylation on FMR1. Neurology. 2017 05 30; 88(22):2070-2071. Nyquist PA, Hagerman R. PMID: 28476761.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    142. The Gut Microbiota and Autism Spectrum Disorders. Front Cell Neurosci. 2017; 11:120. Li Q, Han Y, Dy ABC, Hagerman RJ. PMID: 28503135; PMCID: PMC5408485.
      View in: PubMed   Mentions: 139  
    143. Clinical and molecular correlates in fragile X premutation females. eNeurologicalSci. 2017 Jun; 7:49-56. Jiraanont P, Sweha SR, AlOlaby RR, Silva M, Tang HT, Durbin-Johnson B, Schneider A, Espinal GM, Hagerman PJ, Rivera SM, Hessl D, Hagerman RJ, Chutabhakdikul N, Tassone F. PMID: 28971146; PMCID: PMC5621595.
      View in: PubMed   Mentions: 7  
    144. FMR1 premutation with Prader-Willi phenotype and fragile X-associated tremor/ataxia syndrome. Clin Case Rep. 2017 05; 5(5):625-629. Martínez-Cerdeño V, Lechpammer M, Noctor S, Ariza J, Hagerman P, Hagerman R. PMID: 28469864; PMCID: PMC5412812.
      View in: PubMed   Mentions: 4  
    145. Abnormal trajectories in cerebellum and brainstem volumes in carriers of the fragile X premutation. Neurobiol Aging. 2017 07; 55:11-19. Wang JY, Hessl D, Hagerman RJ, Simon TJ, Tassone F, Ferrer E, Rivera SM. PMID: 28391068; PMCID: PMC5498112.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    146. Language Skills of Males with Fragile X Syndrome or Nonsyndromic Autism Spectrum Disorder. J Autism Dev Disord. 2017 Mar; 47(3):728-743. Thurman AJ, McDuffie A, Hagerman RJ, Josol CK, Abbeduto L. PMID: 28074353; PMCID: PMC5975365.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    147. Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome. Brain. 2017 03 01; 140(3):582-598. Boland MJ, Nazor KL, Tran HT, Szücs A, Lynch CL, Paredes R, Tassone F, Sanna PP, Hagerman RJ, Loring JF. PMID: 28137726; PMCID: PMC5837342.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    148. Molecular biomarkers predictive of sertraline treatment response in young children with fragile X syndrome. Brain Dev. 2017 Jun; 39(6):483-492. AlOlaby RR, Sweha SR, Silva M, Durbin-Johnson B, Yrigollen CM, Pretto D, Hagerman RJ, Tassone F. PMID: 28242040; PMCID: PMC5420478.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    149. Developmental profiles of infants with an FMR1 premutation. J Neurodev Disord. 2016; 8:40. Wheeler AC, Sideris J, Hagerman R, Berry-Kravis E, Tassone F, Bailey DB. PMID: 27822316; PMCID: PMC5095966.
      View in: PubMed   Mentions: 12     Fields:    
    150. The neurobiology of the Prader-Willi phenotype of fragile X syndrome. Intractable Rare Dis Res. 2016 Nov; 5(4):255-261. Muzar Z, Lozano R, Kolevzon A, Hagerman RJ. PMID: 27904820; PMCID: PMC5116860.
      View in: PubMed   Mentions: 8  
    151. Aging in Fragile X Premutation Carriers. Cerebellum. 2016 10; 15(5):587-94. Lozano R, Saito N, Reed D, Eldeeb M, Schneider A, Hessl D, Tassone F, Beckett L, Hagerman R. PMID: 27334385; PMCID: PMC8020959.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    152. A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome. J Dev Behav Pediatr. 2016 10; 37(8):619-28. Greiss Hess L, Fitzpatrick SE, Nguyen DV, Chen Y, Gaul KN, Schneider A, Lemons Chitwood K, Eldeeb MA, Polussa J, Hessl D, Rivera S, Hagerman RJ. PMID: 27560971; PMCID: PMC5039060.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    153. Update on the Clinical, Radiographic, and Neurobehavioral Manifestations in FXTAS and FMR1 Premutation Carriers. Cerebellum. 2016 10; 15(5):578-86. Hall DA, Robertson E, Shelton AL, Losh MC, Mila M, Moreno EG, Gomez-Anson B, Martínez-Cerdeño V, Grigsby J, Lozano R, Hagerman R, Maria LS, Berry-Kravis E, O'Keefe JA. PMID: 27287737; PMCID: PMC7608648.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    154. Altered Bioenergetics in Primary Dermal Fibroblasts from Adult Carriers of the FMR1 Premutation Before the Onset of the Neurodegenerative Disease Fragile X-Associated Tremor/Ataxia Syndrome. Cerebellum. 2016 10; 15(5):552-64. Napoli E, Song G, Wong S, Hagerman R, Giulivi C. PMID: 27089882; PMCID: PMC5014718.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    155. Risk Factors for Cognitive Impairment in Fragile X-Associated Tremor/Ataxia Syndrome. J Geriatr Psychiatry Neurol. 2016 Nov; 29(6):328-337. Seritan AL, Kim K, Benjamin I, Seritan I, Hagerman RJ. PMID: 27647792; PMCID: PMC5357600.
      View in: PubMed   Mentions: 10     Fields:    
    156. Psychiatric disorders among women with the fragile X premutation without children affected by fragile X syndrome. Am J Med Genet B Neuropsychiatr Genet. 2016 12; 171(8):1139-1147. Gossett A, Sansone S, Schneider A, Johnston C, Hagerman R, Tassone F, Rivera SM, Seritan AL, Hessl D. PMID: 27615674; PMCID: PMC6907071.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    157. Clinicians' experiences with the fragile X clinical and research consortium. Am J Med Genet A. 2016 12; 170(12):3138-3143. Liu JA, Hagerman RJ, Miller RM, Craft LT, Finucane B, Tartaglia N, Berry-Kravis EM, Sherman SL, Kidd SA, Cohen J. PMID: 27604509.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    158. Plasma metabolic profile delineates roles for neurodegeneration, pro-inflammatory damage and mitochondrial dysfunction in the FMR1 premutation. Biochem J. 2016 11 01; 473(21):3871-3888. Giulivi C, Napoli E, Tassone F, Halmai J, Hagerman R. PMID: 27555610; PMCID: PMC7014977.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    159. Germinal mosaicism for a deletion of the FMR1 gene leading to fragile X syndrome. Eur J Med Genet. 2016 Sep; 59(9):459-62. Jiraanont P, Hagerman RJ, Neri G, Zollino M, Murdolo M, Tassone F. PMID: 27546052.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    160. Plasma Biomarkers for Monitoring Brain Pathophysiology in FMR1 Premutation Carriers. Front Mol Neurosci. 2016; 9:71. Giulivi C, Napoli E, Tassone F, Halmai J, Hagerman R. PMID: 27570505; PMCID: PMC4981605.
      View in: PubMed   Mentions: 16  
    161. Review of targeted treatments in fragile X syndrome. Intractable Rare Dis Res. 2016 Aug; 5(3):158-67. Ligsay A, Hagerman RJ. PMID: 27672538; PMCID: PMC4995416.
      View in: PubMed   Mentions: 19  
    162. Fragile X syndrome: A review of clinical management. Intractable Rare Dis Res. 2016 Aug; 5(3):145-57. Lozano R, Azarang A, Wilaisakditipakorn T, Hagerman RJ. PMID: 27672537; PMCID: PMC4995426.
      View in: PubMed   Mentions: 35  
    163. Alcohol use dependence in fragile X syndrome. Intractable Rare Dis Res. 2016 Aug; 5(3):207-13. Salcedo-Arellano MJ, Lozano R, Tassone F, Hagerman RJ, Saldarriaga W. PMID: 27672544; PMCID: PMC4995423.
      View in: PubMed   Mentions: 6  
    164. Down Syndrome and Fragile X Syndrome in a Colombian Woman: Case Report. J Appl Res Intellect Disabil. 2017 Sep; 30(5):970-974. Saldarriaga W, Ruiz FA, Tassone F, Hagerman R. PMID: 27456465.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    165. Clinical and Molecular Assessment in a Female with Fragile X Syndrome and Tuberous Sclerosis. J Genet Disord Genet Rep. 2016; 5(3). Yrigollen CM, Pacini L, Nobile V, Lozano R, Hagerman RJ, Bagni C, Tassone F. PMID: 28232951; PMCID: PMC5319728.
      View in: PubMed   Mentions: 1  
    166. Altered redox mitochondrial biology in the neurodegenerative disorder fragile X-tremor/ataxia syndrome: use of antioxidants in precision medicine. Mol Med. 2016 Oct; 22:548-559. Song G, Napoli E, Wong S, Hagerman R, Liu S, Tassone F, Giulivi C. PMID: 27385396; PMCID: PMC5082295.
      View in: PubMed   Mentions: 34     Fields:    
    167. Clinically significant psychiatric symptoms among male carriers of the fragile X premutation, with and without FXTAS, and the mediating influence of executive functioning. Clin Neuropsychol. 2016 Aug; 30(6):944-59. Grigsby J, Brega AG, Bennett RE, Bourgeois JA, Seritan AL, Goodrich GK, Hagerman RJ. PMID: 27355103; PMCID: PMC5011752.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    168. Broad autism spectrum and obsessive-compulsive symptoms in adults with the fragile X premutation. Clin Neuropsychol. 2016 08; 30(6):929-43. Schneider A, Johnston C, Tassone F, Sansone S, Hagerman RJ, Ferrer E, Rivera SM, Hessl D. PMID: 27355445; PMCID: PMC5004987.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    169. Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management. Nat Rev Neurol. 2016 07; 12(7):403-12. Hagerman RJ, Hagerman P. PMID: 27340021.
      View in: PubMed   Mentions: 113     Fields:    Translation:Humans
    170. Warburg effect linked to cognitive-executive deficits in FMR1 premutation. FASEB J. 2016 10; 30(10):3334-3351. Napoli E, Song G, Schneider A, Hagerman R, Eldeeb MA, Azarang A, Tassone F, Giulivi C. PMID: 27335370; PMCID: PMC5024697.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    171. Augmented noncanonical BMP type II receptor signaling mediates the synaptic abnormality of fragile X syndrome. Sci Signal. 2016 06 07; 9(431):ra58. Kashima R, Roy S, Ascano M, Martinez-Cerdeno V, Ariza-Torres J, Kim S, Louie J, Lu Y, Leyton P, Bloch KD, Kornberg TB, Hagerman PJ, Hagerman R, Lagna G, Hata A. PMID: 27273096; PMCID: PMC5274719.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    172. Robust Machine Learning-Based Correction on Automatic Segmentation of the Cerebellum and Brainstem. PLoS One. 2016; 11(5):e0156123. Wang JY, Ngo MM, Hessl D, Hagerman RJ, Rivera SM. PMID: 27213683; PMCID: PMC4877064.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    173. Psychopathology Increases With Age in Fragile X Carrier Mothers. Biol Psychiatry. 2016 05 15; 79(10):790-791. Hagerman R. PMID: 27130851.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    174. Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding. Front Neurosci. 2016; 10:159. Napoli E, Ross-Inta C, Song G, Wong S, Hagerman R, Gane LW, Smilowitz JT, Tassone F, Giulivi C. PMID: 27147951; PMCID: PMC4835505.
      View in: PubMed   Mentions: 22  
    175. Memantine Improves Attentional Processes in Fragile X-Associated Tremor/Ataxia Syndrome: Electrophysiological Evidence from a Randomized Controlled Trial. Sci Rep. 2016 Feb 22; 6:21719. Yang JC, Rodriguez A, Royston A, Niu YQ, Avar M, Brill R, Simon C, Grigsby J, Hagerman RJ, Olichney JM. PMID: 26898832; PMCID: PMC4761982.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    176. Phenobarbital use and neurological problems in FMR1 premutation carriers. Neurotoxicology. 2016 Mar; 53:141-147. Saldarriaga W, Lein P, González Teshima LY, Isaza C, Rosa L, Polyak A, Hagerman R, Girirajan S, Silva M, Tassone F. PMID: 26802682; PMCID: PMC4808401.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    177. Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials. Sci Transl Med. 2016 Jan 13; 8(321):321ra5. Berry-Kravis E, Des Portes V, Hagerman R, Jacquemont S, Charles P, Visootsak J, Brinkman M, Rerat K, Koumaras B, Zhu L, Barth GM, Jaecklin T, Apostol G, von Raison F. PMID: 26764156.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCells
    178. Premutation-Associated Disorders in Childhood and Adulthood. . 2016 Jan 1; 241-262. Hagerman HR, Wheeler WA, Fitzpatrick FS, Hunter HJ. .
      View in: Publisher Site   Mentions:
    179. Treatment and Management of FXTAS. . 2016 Jan 1; 181-197. Hall HD, Leehey LM, Berry-Kravis BE, Hagerman HR. .
      View in: Publisher Site   Mentions:
    180. Clinical Neurological Phenotype of FXTAS. . 2016 Jan 1; 1-24. Leehey LM, Hall HD, Liu LY, Hagerman HR. .
      View in: Publisher Site   Mentions:
    181. Fragile X Syndrome. . 2016 Jan 1; 751-764. Hare HE, Lozano LR, Partington PL, Hagerman HR. .
      View in: Publisher Site   Mentions:
    182. Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism. Psychopharmacology (Berl). 2016 Jan; 233(2):309-23. Kazdoba TM, Hagerman RJ, Zolkowska D, Rogawski MA, Crawley JN. PMID: 26525567; PMCID: PMC4703522.
      View in: PubMed   Mentions: 24     Fields:    Translation:Animals
    183. Identification of a male with fragile X syndrome through newborn screening. Intractable Rare Dis Res. 2015 Nov; 4(4):198-202. Famula J, Basuta K, Gane LW, Hagerman RJ, Tassone F. PMID: 26668780; PMCID: PMC4660861.
      View in: PubMed   Mentions: 3  
    184. The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery. Stem Cells Transl Med. 2015 Nov; 4(11):1369. Brick DJ, Nethercott HE, Montesano S, Banuelos MG, Stover AE, Schutte SS, O'Dowd DK, Hagerman RJ, Ono M, Hessl DR, Tassone F, Schwartz PH. PMID: 26508786; PMCID: PMC4622400.
      View in: PubMed   Mentions:    Fields:    
    185. Prenatal Diagnosis and the Spectrum of Involvement from Fragile X Mutations. . 2015 Oct 23; 350-365. Hagerman HR, Hagerman HP, Hagerman HP. .
      View in: Publisher Site   Mentions:
    186. Characterising repetitive behaviours in young boys with fragile X syndrome. J Intellect Disabil Res. 2016 Jan; 60(1):54-67. Oakes A, Thurman AJ, McDuffie A, Bullard LM, Hagerman RJ, Abbeduto L. PMID: 26449367; PMCID: PMC4715632.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    187. Autism Symptomatology in Boys with Fragile X Syndrome: A Cross Sectional Developmental Trajectories Comparison with Nonsyndromic Autism Spectrum Disorder. J Autism Dev Disord. 2015 Sep; 45(9):2816-32. Thurman AJ, McDuffie A, Kover ST, Hagerman RJ, Abbeduto L. PMID: 25904201; PMCID: PMC4554893.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    188. Fragile X-Associated Tremor/Ataxia Syndrome in a Man in His 30s. JAMA Neurol. 2015 Sep; 72(9):1070-3. Martínez-Cerdeño V, Lechpammer M, Lott A, Schneider A, Hagerman R. PMID: 26368352; PMCID: PMC4629842.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    189. Axonal neuropathy in female carriers of the fragile X premutation with fragile x-associated tremor ataxia syndrome. Muscle Nerve. 2015 Aug; 52(2):234-9. Ram S, Devapriya IA, Fenton G, Mcvay L, Nguyen DV, Tassone F, Maselli RA, Hagerman RJ. PMID: 25388402; PMCID: PMC4427531.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    190. Psychosis and catatonia in fragile X: Case report and literature review. Intractable Rare Dis Res. 2015 Aug; 4(3):139-46. Winarni TI, Schneider A, Ghaziuddin N, Seritan A, Hagerman RJ. PMID: 26361565; PMCID: PMC4561243.
      View in: PubMed   Mentions: 6  
    191. Anxiety disorders in fragile X premutation carriers: Preliminary characterization of probands and non-probands. Intractable Rare Dis Res. 2015 Aug; 4(3):123-30. Cordeiro L, Abucayan F, Hagerman R, Tassone F, Hessl D. PMID: 26361563; PMCID: PMC4561241.
      View in: PubMed   Mentions: 25  
    192. Maternal Consequences of the Detection of Fragile X Carriers in Newborn Screening. Pediatrics. 2015 Aug; 136(2):e433-40. Bailey DB, Wheeler A, Berry-Kravis E, Hagerman R, Tassone F, Powell CM, Roche M, Gane LW, Sideris J. PMID: 26169437; PMCID: PMC4516945.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    193. Symptoms of Autism in Males with Fragile X Syndrome: A Comparison to Nonsyndromic ASD Using Current ADI-R Scores. J Autism Dev Disord. 2015 Jul; 45(7):1925-37. McDuffie A, Thurman AJ, Hagerman RJ, Abbeduto L. PMID: 24414079; PMCID: PMC4096070.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    194. Detection of skewed X-chromosome inactivation in Fragile X syndrome and X chromosome aneuploidy using quantitative melt analysis. Expert Rev Mol Med. 2015 Jul 01; 17:e13. Godler DE, Inaba Y, Schwartz CE, Bui QM, Shi EZ, Li X, Herlihy AS, Skinner C, Hagerman RJ, Francis D, Amor DJ, Metcalfe SA, Hopper JL, Slater HR. PMID: 26132880; PMCID: PMC4836209.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    195. High functioning male with fragile X syndrome and fragile X-associated tremor/ataxia syndrome. Am J Med Genet A. 2015 Sep; 167A(9):2154-61. Basuta K, Schneider A, Gane L, Polussa J, Woodruff B, Pretto D, Hagerman R, Tassone F. PMID: 25920745.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    196. Methadone use in a male with the FMRI premutation and FXTAS. Am J Med Genet A. 2015 Jun; 167(6):1354-9. Muzar Z, Lozano R, Schneider A, Adams PE, Faradz SM, Tassone F, Hagerman RJ. PMID: 25900641; PMCID: PMC4845901.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    197. Erratum: Emerging topics in FXTAS. J Neurodev Disord. 2015; 7(1):13. Hall DA, Birch RC, Anheim M, Jønch AE, Pintado E, O'Keefe JA, Trollor JN, Stebbins GT, Hagerman RJ, Fahn S, Berry-Kravis E, Leehey MA. PMID: 25852777; PMCID: PMC4387583.
      View in: PubMed   Mentions: 1     Fields:    
    198. Effect of speaker gaze on word learning in fragile X syndrome: a comparison with nonsyndromic autism spectrum disorder. J Speech Lang Hear Res. 2015 Apr; 58(2):383-95. Benjamin DP, McDuffie AS, Thurman AJ, Kover ST, Mastergeorge AM, Hagerman RJ, Abbeduto L. PMID: 25629603; PMCID: PMC4675125.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    199. Use of emotional cues for lexical learning: a comparison of autism spectrum disorder and fragile X syndrome. J Autism Dev Disord. 2015 Apr; 45(4):1042-61. Thurman AJ, McDuffie A, Kover ST, Hagerman R, Channell MM, Mastergeorge A, Abbeduto L. PMID: 25318904; PMCID: PMC4369166.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    200. Treatment of the psychiatric problems associated with fragile X syndrome. Curr Opin Psychiatry. 2015 Mar; 28(2):107-12. Hagerman RJ, Polussa J. PMID: 25602250; PMCID: PMC6084462.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    201. Fragile X-associated tremor/ataxia syndrome. Ann N Y Acad Sci. 2015 Mar; 1338:58-70. Hagerman PJ, Hagerman RJ. PMID: 25622649; PMCID: PMC4363162.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansAnimalsCells
    202. Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder. Curr Pharm Des. 2015; 21(34):4972-4979. Lozano R, Martinez-Cerdeno V, Hagerman RJ. PMID: 26365141; PMCID: PMC4830341.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    203. Chapter 17 Fragile X-Associated Disorders. . 2015 Jan 1; 183-195. Lozano LR, Hare HE, Hagerman HR. .
      View in: Publisher Site   Mentions:
    204. Fragile X syndrome. Colomb Med (Cali). 2014 Oct-Dec; 45(4):190-8. Saldarriaga W, Tassone F, González-Teshima LY, Forero-Forero JV, Ayala-Zapata S, Hagerman R. PMID: 25767309; PMCID: PMC4350386.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansAnimalsCells
    205. Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome. Brain Res. 2015 Feb 19; 1598:88-96. Ariza J, Steward C, Rueckert F, Widdison M, Coffman R, Afjei A, Noctor SC, Hagerman R, Hagerman P, Martínez-Cerdeño V. PMID: 25498860; PMCID: PMC4340768.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    206. Immune mediated disorders in women with a fragile X expansion and FXTAS. Am J Med Genet A. 2015 Jan; 167A(1):190-7. Jalnapurkar I, Rafika N, Tassone F, Hagerman R. PMID: 25399540; PMCID: PMC4275322.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    207. Serotonin dysregulation in Fragile X Syndrome: implications for treatment. Intractable Rare Dis Res. 2014 Nov; 3(4):110-7. Hanson AC, Hagerman RJ. PMID: 25606361; PMCID: PMC4298641.
      View in: PubMed   Mentions: 16  
    208. Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two cases. Intractable Rare Dis Res. 2014 Nov; 3(4):162-5. Muzar Z, Adams PE, Schneider A, Hagerman RJ, Lozano R. PMID: 25606366; PMCID: PMC4298646.
      View in: PubMed   Mentions: 21  
    209. Parent-delivered touchscreen intervention for children with fragile X syndrome. Intractable Rare Dis Res. 2014 Nov; 3(4):166-77. Díez-Juan M, Schneider A, Phillips T, Lozano R, Tassone F, Solomon M, Hagerman RJ. PMID: 25606367; PMCID: PMC4298647.
      View in: PubMed   Mentions: 4  
    210. Translational research guided by animal studies in Fragile X Disorders. Intractable Rare Dis Res. 2014 Nov; 3(4):100. Hagerman R, Lozano R, Schneider A. PMID: 25606359; PMCID: PMC4298639.
      View in: PubMed   Mentions:
    211. Fragile X spectrum disorders. Intractable Rare Dis Res. 2014 Nov; 3(4):134-46. Lozano R, Rosero CA, Hagerman RJ. PMID: 25606363; PMCID: PMC4298643.
      View in: PubMed   Mentions: 79  
    212. Participation of underrepresented minority children in clinical trials for Fragile X syndrome and other neurodevelopmental disorders. Intractable Rare Dis Res. 2014 Nov; 3(4):147-52. Chechi T, Siyahian S, Thairu L, Hagerman R, Lozano R. PMID: 25606364; PMCID: PMC4298644.
      View in: PubMed   Mentions: 2  
    213. The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery. Stem Cells Transl Med. 2014 Nov; 3(11):1275-86. Brick DJ, Nethercott HE, Montesano S, Banuelos MG, Stover AE, Schutte SS, O'Dowd DK, Hagerman RJ, Ono M, Hessl DR, Tassone F, Schwartz PH. PMID: 25273538; PMCID: PMC4214842.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsCTClinical Trials
    214. Emotion potentiated startle in fragile X syndrome. J Autism Dev Disord. 2014 Oct; 44(10):2536-46. Ballinger EC, Cordeiro L, Chavez AD, Hagerman RJ, Hessl D. PMID: 24816942; PMCID: PMC4167929.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    215. Clinical and molecular implications of mosaicism in FMR1 full mutations. Front Genet. 2014; 5:318. Pretto D, Yrigollen CM, Tang HT, Williamson J, Espinal G, Iwahashi CK, Durbin-Johnson B, Hagerman RJ, Hagerman PJ, Tassone F. PMID: 25278957; PMCID: PMC4166380.
      View in: PubMed   Mentions: 56  
    216. Modulation of the GABAergic pathway for the treatment of fragile X syndrome. Neuropsychiatr Dis Treat. 2014; 10:1769-79. Lozano R, Hare EB, Hagerman RJ. PMID: 25258535; PMCID: PMC4172237.
      View in: PubMed   Mentions: 32  
    217. A feasibility trial of Cogmed working memory training in fragile X syndrome. J Pediatr Genet. 2014 Sep; 3(3):147-56. Au J, Berkowitz-Sutherland L, Schneider A, Schweitzer JB, Hessl D, Hagerman R. PMID: 27625871; PMCID: PMC5021004.
      View in: PubMed   Mentions: 11  
    218. ERP abnormalities elicited by word repetition in fragile X-associated tremor/ataxia syndrome (FXTAS) and amnestic MCI. Neuropsychologia. 2014 Oct; 63:34-42. Yang JC, Chi L, Teichholtz S, Schneider A, Nanakul R, Nowacki R, Seritan A, Reed B, DeCarli C, Iragui VJ, Kutas M, Hagerman PJ, Hagerman RJ, Olichney JM. PMID: 25111034; PMCID: PMC4194142.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    219. Sentence comprehension in boys with autism spectrum disorder. Am J Speech Lang Pathol. 2014 Aug; 23(3):385-94. Kover ST, Haebig E, Oakes A, McDuffie A, Hagerman RJ, Abbeduto L. PMID: 24687049; PMCID: PMC4119529.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    220. Prevalence of restless legs syndrome and sleep quality in carriers of the fragile X premutation. Clin Genet. 2014 Aug; 86(2):181-4. Summers SM, Cogswell J, Goodrich JE, Mu Y, Nguyen DV, Brass SD, Hagerman RJ. PMID: 25180401; PMCID: PMC4391968.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    221. Associated features in females with an FMR1 premutation. J Neurodev Disord. 2014; 6(1):30. Wheeler AC, Bailey DB, Berry-Kravis E, Greenberg J, Losh M, Mailick M, Milà M, Olichney JM, Rodriguez-Revenga L, Sherman S, Smith L, Summers S, Yang JC, Hagerman R. PMID: 25097672; PMCID: PMC4121434.
      View in: PubMed   Mentions: 75     Fields:    
    222. Emerging topics in FXTAS. J Neurodev Disord. 2014; 6(1):31. Hall DA, Birch RC, Anheim M, Jønch AE, Pintado E, O'Keefe J, Trollor JN, Stebbins GT, Hagerman RJ, Fahn S, Berry-Kravis E, Leehey MA. PMID: 25642984; PMCID: PMC4141265.
      View in: PubMed   Mentions: 39     Fields:    
    223. Fragile x premutation. J Neurodev Disord. 2014; 6(1):22. Tassone F, Hagerman PJ, Hagerman RJ. PMID: 25170346; PMCID: PMC4147873.
      View in: PubMed   Mentions: 10     Fields:    
    224. Genomic studies in fragile X premutation carriers. J Neurodev Disord. 2014; 6(1):27. Lozano R, Hagerman RJ, Duyzend M, Budimirovic DB, Eichler EE, Tassone F. PMID: 25170347; PMCID: PMC4147387.
      View in: PubMed   Mentions: 12     Fields:    
    225. Effects of labeling and pointing on object gaze in boys with fragile X syndrome: an eye-tracking study. Res Dev Disabil. 2014 Nov; 35(11):2658-72. Benjamin DP, Mastergeorge AM, McDuffie AS, Kover ST, Hagerman RJ, Abbeduto L. PMID: 25062097; PMCID: PMC4154990.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    226. Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome. J Neuroinflammation. 2014 Jun 19; 11:110. Careaga M, Noyon T, Basuta K, Van de Water J, Tassone F, Hagerman RJ, Ashwood P. PMID: 24942544; PMCID: PMC4107617.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    227. Association between macroorchidism and intelligence in FMR1 premutation carriers. Am J Med Genet A. 2014 Sep; 164A(9):2206-11. Lozano R, Summers S, Lozano C, Mu Y, Hessl D, Nguyen D, Tassone F, Hagerman R. PMID: 24903624; PMCID: PMC4332881.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    228. Targeted treatments in fragile X syndrome. Expert Opinion on Orphan Drugs. 2014 Jun 1; 2(6):531-543. Hare HE, Hagerman HR, Lozano LR. .
      View in: Publisher Site   Mentions:
    229. Memantine effects on verbal memory in fragile X-associated tremor/ataxia syndrome (FXTAS): a double-blind brain potential study. Neuropsychopharmacology. 2014 Nov; 39(12):2760-8. Yang JC, Niu YQ, Simon C, Seritan AL, Chen L, Schneider A, Moghaddam ST, Hagerman PJ, Hagerman RJ, Olichney JM. PMID: 24871547; PMCID: PMC4200486.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    230. Staged transthoracic approach to persistent atrial fibrillation (TOP-AF): study protocol for a randomized trial. Trials. 2014 May 26; 15:190. Pragliola C, Mastroroberto P, Gaudino M, Chello M, Covino E. PMID: 24885377; PMCID: PMC4066274.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    231. Early detection of fragile X syndrome: applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spots. Clin Chem. 2014 Jul; 60(7):963-73. Inaba Y, Schwartz CE, Bui QM, Li X, Skinner C, Field M, Wotton T, Hagerman RJ, Francis D, Amor DJ, Hopper JL, Loesch DZ, Bretherton L, Slater HR, Godler DE. PMID: 24778142.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    232. Immune dysregulation as a cause of autoinflammation in fragile X premutation carriers: link between FMRI CGG repeat number and decreased cytokine responses. PLoS One. 2014; 9(4):e94475. Careaga M, Rose D, Tassone F, Berman RF, Hagerman R, Ashwood P. PMID: 24718368; PMCID: PMC3981824.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    233. Translating molecular advances in fragile X syndrome into therapy: a review. J Clin Psychiatry. 2014 Apr; 75(4):e294-307. Hagerman RJ, Des-Portes V, Gasparini F, Jacquemont S, Gomez-Mancilla B. PMID: 24813413.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimals
    234. Psychiatric symptoms in boys with fragile X syndrome: a comparison with nonsyndromic autism spectrum disorder. Res Dev Disabil. 2014 May; 35(5):1072-86. Thurman AJ, McDuffie A, Hagerman R, Abbeduto L. PMID: 24629733; PMCID: PMC4009990.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    235. CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles. J Med Genet. 2014 May; 51(5):309-18. Pretto DI, Mendoza-Morales G, Lo J, Cao R, Hadd A, Latham GJ, Durbin-Johnson B, Hagerman R, Tassone F. PMID: 24591415; PMCID: PMC4010431.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    236. Towards an Understanding of Neuropsychiatric Manifestations in Fragile X Premutation Carriers. Future Neurol. 2014 Mar; 9(2):227-239. Besterman AD, Wilke SA, Mulligan TE, Allison SC, Hagerman R, Seritan AL, Bourgeois JA. PMID: 25013385; PMCID: PMC4086747.
      View in: PubMed   Mentions: 15  
    237. Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2014 Mar; 75(3):264-71. Seritan AL, Nguyen DV, Mu Y, Tassone F, Bourgeois JA, Schneider A, Cogswell JB, Cook KR, Leehey MA, Grigsby J, Olichney JM, Adams PE, Legg W, Zhang L, Hagerman PJ, Hagerman RJ. PMID: 24345444; PMCID: PMC4296896.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    238. Psychological status in female carriers of premutation FMR1 allele showing a complex relationship with the size of CGG expansion. Clin Genet. 2015 Feb; 87(2):173-8. Loesch DZ, Bui MQ, Hammersley E, Schneider A, Storey E, Stimpson P, Burgess T, Francis D, Slater H, Tassone F, Hagerman RJ, Hessl D. PMID: 24428240; PMCID: PMC4115039.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    239. Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited. Parkinsonism Relat Disord. 2014 Apr; 20(4):456-9. Niu YQ, Yang JC, Hall DA, Leehey MA, Tassone F, Olichney JM, Hagerman RJ, Zhang L. PMID: 24491663; PMCID: PMC4019503.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    240. Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers. Brain Disord Ther. 2014; 3. Polussa J, Schneider A, Hagerman R. PMID: 25436181; PMCID: PMC4245015.
      View in: PubMed   Mentions: 34  
    241. Abnormal semantic processing in females with fragile X-associated tremor/ataxia syndrome. Genes Brain Behav. 2014 Feb; 13(2):152-62. Yang JC, Simon C, Schneider A, Seritan AL, Hamilton L, Hagerman PJ, Hagerman RJ, Olichney JM. PMID: 24299169; PMCID: PMC3905835.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    242. Development of mavoglurant and its potential for the treatment of fragile X syndrome. Expert Opin Investig Drugs. 2014 Jan; 23(1):125-34. Gomez-Mancilla B, Berry-Kravis E, Hagerman R, von Raison F, Apostol G, Ufer M, Gasparini F, Jacquemont S. PMID: 24251408.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    243. Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome. Neurobiol Aging. 2014 May; 35(5):1189-97. Pretto DI, Kumar M, Cao Z, Cunningham CL, Durbin-Johnson B, Qi L, Berman R, Noctor SC, Hagerman RJ, Pessah IN, Tassone F. PMID: 24332449; PMCID: PMC4062976.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    244. Receptive vocabulary in boys with autism spectrum disorder: cross-sectional developmental trajectories. J Autism Dev Disord. 2013 Nov; 43(11):2696-709. Kover ST, McDuffie AS, Hagerman RJ, Abbeduto L. PMID: 23588510; PMCID: PMC3797266.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    245. The challenges of clinical trials in fragile X syndrome. Psychopharmacology (Berl). 2014 Mar; 231(6):1237-50. Jacquemont S, Berry-Kravis E, Hagerman R, von Raison F, Gasparini F, Apostol G, Ufer M, Des Portes V, Gomez-Mancilla B. PMID: 24173622; PMCID: PMC3932172.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimals
    246. FXTAS in an unmethylated mosaic male with fragile X syndrome from Chile. Clin Genet. 2014 Oct; 86(4):378-82. Santa María L, Pugin A, Alliende MA, Aliaga S, Curotto B, Aravena T, Tang HT, Mendoza-Morales G, Hagerman R, Tassone F. PMID: 24028275; PMCID: PMC4004716.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    247. Electrocortical changes associated with minocycline treatment in fragile X syndrome. J Psychopharmacol. 2013 Oct; 27(10):956-63. Schneider A, Leigh MJ, Adams P, Nanakul R, Chechi T, Olichney J, Hagerman R, Hessl D. PMID: 23981511; PMCID: PMC4962861.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    248. Phenotypes of hypofrontality in older female fragile X premutation carriers. Ann Neurol. 2013 Aug; 74(2):275-83. Yang JC, Simon C, Niu YQ, Bogost M, Schneider A, Tassone F, Seritan A, Grigsby J, Hagerman PJ, Hagerman RJ, Olichney JM. PMID: 23686745; PMCID: PMC3906211.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    249. Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome. Lancet Neurol. 2013 Aug; 12(8):786-98. Hagerman R, Hagerman P. PMID: 23867198; PMCID: PMC3922535.
      View in: PubMed   Mentions: 182     Fields:    Translation:HumansCells
    250. Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles. JAMA Neurol. 2013 Aug; 70(8):1022-9. Wang JY, Hessl D, Schneider A, Tassone F, Hagerman RJ, Rivera SM. PMID: 23753897; PMCID: PMC4028037.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    251. A family with two female siblings with compound heterozygous FMR1 premutation alleles. Clin Genet. 2014 May; 85(5):458-63. Basuta K, Lozano R, Schneider A, Yrigollen CM, Hessl D, Hagerman RJ, Tassone F. PMID: 23786467; PMCID: PMC3996450.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    252. High MMP-9 activity levels in fragile X syndrome are lowered by minocycline. Am J Med Genet A. 2013 Aug; 161A(8):1897-903. Dziembowska M, Pretto DI, Janusz A, Kaczmarek L, Leigh MJ, Gabriel N, Durbin-Johnson B, Hagerman RJ, Tassone F. PMID: 23824974.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansAnimalsCells
    253. Investigating word learning in fragile X syndrome: a fast-mapping study. J Autism Dev Disord. 2013 Jul; 43(7):1676-91. McDuffie A, Kover ST, Hagerman R, Abbeduto L. PMID: 23179343; PMCID: PMC3620772.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    254. Transmission of an FMR1 premutation allele in a large family identified through newborn screening: the role of AGG interruptions. J Hum Genet. 2013 Aug; 58(8):553-9. Yrigollen CM, Mendoza-Morales G, Hagerman R, Tassone F. PMID: 23739124; PMCID: PMC4003888.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsPHPublic Health
    255. Intranuclear inclusions in a fragile X mosaic male. Transl Neurodegener. 2013 May 21; 2(1):10. Pretto DI, Hunsaker MR, Cunningham CL, Greco CM, Hagerman RJ, Noctor SC, Hall DA, Hagerman PJ, Tassone F. PMID: 23692864; PMCID: PMC3668897.
      View in: PubMed   Mentions: 24     Fields:    
    256. A multimodal imaging analysis of subcortical gray matter in fragile X premutation carriers. Mov Disord. 2013 Aug; 28(9):1278-84. Wang JY, Hagerman RJ, Rivera SM. PMID: 23649693; PMCID: PMC3785985.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    257. A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome. J Dev Behav Pediatr. 2013 Apr; 34(3):147-55. Leigh MJ, Nguyen DV, Mu Y, Winarni TI, Schneider A, Chechi T, Polussa J, Doucet P, Tassone F, Rivera SM, Hessl D, Hagerman RJ. PMID: 23572165; PMCID: PMC3706260.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    258. Prevalence and risk of migraine headaches in adult fragile X premutation carriers. Clin Genet. 2013 Dec; 84(6):546-51. Au J, Akins RS, Berkowitz-Sutherland L, Tang HT, Chen Y, Boyd A, Tassone F, Nguyen DV, Hagerman R. PMID: 23373759; PMCID: PMC4991825.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    259. Fragile X syndrome: clinical, cytogenetic and molecular screening among autism spectrum disorder children in Indonesia. Clin Genet. 2013 Dec; 84(6):577-80. Winarni TI, Utari A, Mundhofir FE, Hagerman RJ, Faradz SM. PMID: 23320543.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    260. Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers. Curr Psychiatry Rev. 2013 Feb; 9(1):65-71. Seritan AL, Bourgeois JA, Schneider A, Mu Y, Hagerman RJ, Nguyen DV. PMID: 25844075; PMCID: PMC4383251.
      View in: PubMed   Mentions: 20  
    261. Epilepsy drives autism in neurodevelopmental disorders. Dev Med Child Neurol. 2013 Feb; 55(2):101-102. Hagerman RJ. PMID: 23320573; PMCID: PMC4051495.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    262. FRAGILE X SYNDROME: PSYCHIATRIC MANIFESTATIONS, ASSESSMENT AND EMERGING THERAPIES. Curr Psychiatry Rev. 2013 Feb 01; 9(1):53-58. Wadell PM, Hagerman RJ, Hessl DR. PMID: 25632275; PMCID: PMC4306413.
      View in: PubMed   Mentions: 15  
    263. Relationships between age and epi-genotype of the FMR1 exon 1/intron 1 boundary are consistent with non-random X-chromosome inactivation in FM individuals, with the selection for the unmethylated state being most significant between birth and puberty. Hum Mol Genet. 2013 Apr 15; 22(8):1516-24. Godler DE, Inaba Y, Shi EZ, Skinner C, Bui QM, Francis D, Amor DJ, Hopper JL, Loesch DZ, Hagerman RJ, Schwartz CE, Slater HR. PMID: 23307923; PMCID: PMC3605829.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    264. PSYCHIATRIC DISORDERS ASSOCIATED WITH FXTAS. Curr Psychiatry Rev. 2013; 9(1):59-64. Seritan AL, Ortigas M, Seritan S, Bourgeois JA, Hagerman RJ. PMID: 25620899; PMCID: PMC4304643.
      View in: PubMed   Mentions: 16  
    265. Psychiatric features in high-functioning adult brothers with fragile x spectrum disorders. Prim Care Companion CNS Disord. 2013; 15(2). Schneider A, Seritan A, Tassone F, Rivera SM, Hagerman R, Hessl D. PMID: 23930232; PMCID: PMC3733525.
      View in: PubMed   Mentions: 8     Fields:    
    266. Fragile X syndrome: an aging perspective. Dev Disabil Res Rev. 2013; 18(1):68-74. Schneider A, Ligsay A, Hagerman RJ. PMID: 23949830; PMCID: PMC4959461.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    267. Neurodevelopmental disabilities in children with intermediate and premutation range fragile X cytosine-guanine-guanine expansions. J Child Neurol. 2014 Mar; 29(3):326-30. Renda MM, Voigt RG, Babovic-Vuksanovic D, Highsmith WE, Vinson SS, Sadowski CM, Hagerman RJ. PMID: 23266944.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    268. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med. 2012; 4(12):100. Tassone F, Iong KP, Tong TH, Lo J, Gane LW, Berry-Kravis E, Nguyen D, Mu LY, Laffin J, Bailey DB, Hagerman RJ. PMID: 23259642; PMCID: PMC4064316.
      View in: PubMed   Mentions: 156     Fields:    
    269. Newborn screening and cascade testing for FMR1 mutations. Am J Med Genet A. 2013 Jan; 161A(1):59-69. Sorensen PL, Gane LW, Yarborough M, Hagerman RJ, Tassone F. PMID: 23239591; PMCID: PMC3980469.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    270. Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. J Clin Invest. 2012 Dec; 122(12):4314-22. Bagni C, Tassone F, Neri G, Hagerman R. PMID: 23202739; PMCID: PMC3533539.
      View in: PubMed   Mentions: 149     Fields:    Translation:HumansAnimalsCells
    271. Newborn, carrier, and early childhood screening recommendations for fragile X. Pediatrics. 2012 Dec; 130(6):1126-35. Abrams L, Cronister A, Brown WT, Tassone F, Sherman SL, Finucane B, McConkie-Rosell A, Hagerman R, Kaufmann WE, Picker J, Coffey S, Skinner D, Johnson V, Miller R, Berry-Kravis E. PMID: 23129072.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    272. Fragile X-associated tremor/ataxia syndrome (FXTAS) in grey zone carriers. Clin Genet. 2013 Jul; 84(1):74-7. Liu Y, Winarni TI, Zhang L, Tassone F, Hagerman RJ. PMID: 23009394; PMCID: PMC4991824.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    273. Influence of the fragile X mental retardation (FMR1) gene on the brain and working memory in men with normal FMR1 alleles. Neuroimage. 2013 Jan 15; 65:288-98. Wang JY, Hessl D, Iwahashi C, Cheung K, Schneider A, Hagerman RJ, Hagerman PJ, Rivera SM. PMID: 23063447; PMCID: PMC3540208.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    274. Fragile X-related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study. Genet Med. 2013 Apr; 15(4):290-8. Inaba Y, Herlihy AS, Schwartz CE, Skinner C, Bui QM, Cobb J, Shi EZ, Francis D, Arvaj A, Amor DJ, Pope K, Wotton T, Cohen J, Hewitt JK, Hagerman RJ, Metcalfe SA, Hopper JL, Loesch DZ, Slater HR, Godler DE. PMID: 23060046.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCellsPHPublic Health
    275. Sequencing the unsequenceable: expanded CGG-repeat alleles of the fragile X gene. Genome Res. 2013 Jan; 23(1):121-8. Loomis EW, Eid JS, Peluso P, Yin J, Hickey L, Rank D, McCalmon S, Hagerman RJ, Tassone F, Hagerman PJ. PMID: 23064752; PMCID: PMC3530672.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCells
    276. Treatment of neurodevelopmental disorders in adulthood. J Neurosci. 2012 Oct 10; 32(41):14074-9. Castrén E, Elgersma Y, Maffei L, Hagerman R. PMID: 23055475; PMCID: PMC3500763.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimals
    277. TARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROME. Res Autism Spectr Disord. 2012 Oct 01; 6(4):1311-1320. Gürkan CK, Hagerman RJ. PMID: 23162607; PMCID: PMC3498468.
      View in: PubMed   Mentions: 17  
    278. Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial. Sci Transl Med. 2012 Sep 19; 4(152):152ra127. Berry-Kravis EM, Hessl D, Rathmell B, Zarevics P, Cherubini M, Walton-Bowen K, Mu Y, Nguyen DV, Gonzalez-Heydrich J, Wang PP, Carpenter RL, Bear MF, Hagerman RJ. PMID: 22993294.
      View in: PubMed   Mentions: 162     Fields:    Translation:HumansCTClinical Trials
    279. Neural substrates of executive dysfunction in fragile X-associated tremor/ataxia syndrome (FXTAS): a brain potential study. Cereb Cortex. 2013 Nov; 23(11):2657-66. Yang JC, Chan SH, Khan S, Schneider A, Nanakul R, Teichholtz S, Niu YQ, Seritan A, Tassone F, Grigsby J, Hagerman PJ, Hagerman RJ, Olichney JM. PMID: 22918986; PMCID: PMC3792740.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    280. Immune-mediated disorders among women carriers of fragile X premutation alleles. Am J Med Genet A. 2012 Oct; 158A(10):2473-81. Winarni TI, Chonchaiya W, Sumekar TA, Ashwood P, Morales GM, Tassone F, Nguyen DV, Faradz SM, Van de Water J, Cook K, Hamlin A, Mu Y, Hagerman PJ, Hagerman RJ. PMID: 22903889; PMCID: PMC4105154.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    281. The fragile X-associated tremor ataxia syndrome (FXTAS) in Indonesia. Clin Genet. 2013 Mar; 83(3):263-8. Winarni TI, Mundhofir FE, Ediati A, Belladona M, Nillesen WM, Yntema HG, Hamel BC, Faradz SM, Hagerman RJ. PMID: 22568721.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    282. Sertraline may improve language developmental trajectory in young children with fragile x syndrome: a retrospective chart review. Autism Res Treat. 2012; 2012:104317. Indah Winarni T, Chonchaiya W, Adams E, Au J, Mu Y, Rivera SM, Nguyen DV, Hagerman RJ. PMID: 22934167; PMCID: PMC3420618.
      View in: PubMed   Mentions: 24  
    283. Signaling defects in iPSC-derived fragile X premutation neurons. Hum Mol Genet. 2012 Sep 01; 21(17):3795-805. Liu J, Koscielska KA, Cao Z, Hulsizer S, Grace N, Mitchell G, Nacey C, Githinji J, McGee J, Garcia-Arocena D, Hagerman RJ, Nolta J, Pessah IN, Hagerman PJ. PMID: 22641815; PMCID: PMC3412379.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    284. Hypertension in FMR1 premutation males with and without fragile X-associated tremor/ataxia syndrome (FXTAS). Am J Med Genet A. 2012 Jun; 158A(6):1304-9. Hamlin AA, Sukharev D, Campos L, Mu Y, Tassone F, Hessl D, Nguyen DV, Loesch D, Hagerman RJ. PMID: 22528549; PMCID: PMC3983689.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    285. AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet Med. 2012 Aug; 14(8):729-36. Yrigollen CM, Durbin-Johnson B, Gane L, Nelson DL, Hagerman R, Hagerman PJ, Tassone F. PMID: 22498846; PMCID: PMC3990283.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCells
    286. A fragile X sibship from a consanguineous family with a compound heterozygous female and partially methylated full mutation male. Am J Med Genet A. 2012 May; 158A(5):1221-4. Sorensen PL, Basuta K, Mendoza-Morales G, Gane LW, Schneider A, Hagerman R, Tassone F. PMID: 22488807; PMCID: PMC3331966.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    287. Reduced telomere length in individuals with FMR1 premutations and full mutations. Am J Med Genet A. 2012 May; 158A(5):1060-5. Jenkins EC, Tassone F, Ye L, Hoogeveen AT, Brown WT, Hagerman RJ, Hagerman PJ. PMID: 22489017; PMCID: PMC3402180.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    288. Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. Genes Brain Behav. 2012 Jul; 11(5):577-85. Tassone F, Greco CM, Hunsaker MR, Seritan AL, Berman RF, Gane LW, Jacquemont S, Basuta K, Jin LW, Hagerman PJ, Hagerman RJ. PMID: 22463693; PMCID: PMC3965773.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCells
    289. Age-dependent structural connectivity effects in fragile x premutation. Arch Neurol. 2012 Apr; 69(4):482-9. Wang JY, Hessl DH, Hagerman RJ, Tassone F, Rivera SM. PMID: 22491193; PMCID: PMC3979438.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    290. Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone. Hum Mol Genet. 2012 Jul 01; 21(13):2923-35. Cao Z, Hulsizer S, Tassone F, Tang HT, Hagerman RJ, Rogawski MA, Hagerman PJ, Pessah IN. PMID: 22466801; PMCID: PMC3373240.
      View in: PubMed   Mentions: 65     Fields:    Translation:AnimalsCells
    291. Early intervention combined with targeted treatment promotes cognitive and behavioral improvements in young children with fragile x syndrome. Case Rep Genet. 2012; 2012:280813. Winarni TI, Schneider A, Borodyanskara M, Hagerman RJ. PMID: 23074686; PMCID: PMC3447258.
      View in: PubMed   Mentions: 28  
    292. Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes Brain Behav. 2012 Apr; 11(3):332-41. Hoeffer CA, Sanchez E, Hagerman RJ, Mu Y, Nguyen DV, Wong H, Whelan AM, Zukin RS, Klann E, Tassone F. PMID: 22268788; PMCID: PMC3319643.
      View in: PubMed   Mentions: 107     Fields:    Translation:HumansCells
    293. Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot study. Clin Chem. 2012 Mar; 58(3):590-8. Godler DE, Slater HR, Bui QM, Storey E, Ono MY, Gehling F, Inaba Y, Francis D, Hopper JL, Kinsella G, Amor DJ, Hagerman RJ, Loesch DZ. PMID: 22235103.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    294. Unstable mutations in the FMR1 gene and the phenotypes. Adv Exp Med Biol. 2012; 769:78-114. Loesch D, Hagerman R. PMID: 23560306; PMCID: PMC4124039.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    295. The fragile X-associated tremor ataxia syndrome. Results Probl Cell Differ. 2012; 54:337-57. Tassone F, Hagerman R. PMID: 22009361.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    296. Fragile X syndrome and targeted treatment trials. Results Probl Cell Differ. 2012; 54:297-335. Hagerman R, Lauterborn J, Au J, Berry-Kravis E. PMID: 22009360; PMCID: PMC4114775.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimalsCells
    297. Investigation of amygdala volume in men with the fragile X premutation. Brain Imaging Behav. 2011 Dec; 5(4):285-94. Selmeczy D, Koldewyn K, Wang JM, Lee A, Harvey D, Hessl DR, Tassone F, Adams P, Hagerman RJ, Hagerman PJ, Rivera SM. PMID: 21786216; PMCID: PMC3982607.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    298. Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Man with Fragile X-associated Tremor/Ataxia Syndrome. Case Rep Genet. 2011; 2011:143132. Sumekar TA, Ashrani AA, Winarni TI, Hagerman RJ. PMID: 23074671; PMCID: PMC3447231.
      View in: PubMed   Mentions: 1  
    299. The fragile X-associated disorders: time to order fragile X DNA testing. Biol Psychiatry. 2011 Nov 01; 70(9):802-3. Hagerman RJ. PMID: 21986091.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    300. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Hum Genet. 2012 Apr; 131(4):581-9. Chonchaiya W, Au J, Schneider A, Hessl D, Harris SW, Laird M, Mu Y, Tassone F, Nguyen DV, Hagerman RJ. PMID: 22001913; PMCID: PMC4105134.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    301. Sleep apnea in fragile X premutation carriers with and without FXTAS. Am J Med Genet B Neuropsychiatr Genet. 2011 Dec; 156B(8):923-8. Hamlin A, Liu Y, Nguyen DV, Tassone F, Zhang L, Hagerman RJ. PMID: 21932336; PMCID: PMC4109408.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    302. Fibromyalgia in fragile X mental retardation 1 gene premutation carriers. Rheumatology (Oxford). 2011 Dec; 50(12):2233-6. Leehey MA, Legg W, Tassone F, Hagerman R. PMID: 21926154; PMCID: PMC3222847.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    303. Testing the FMR1 promoter for mosaicism in DNA methylation among CpG sites, strands, and cells in FMR1-expressing males with fragile X syndrome. PLoS One. 2011; 6(8):e23648. Stöger R, Genereux DP, Hagerman RJ, Hagerman PJ, Tassone F, Laird CD. PMID: 21909353; PMCID: PMC3166088.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    304. Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice. Acta Neuropathol. 2011 Oct; 122(4):467-79. Hunsaker MR, Greco CM, Spath MA, Smits AP, Navarro CS, Tassone F, Kros JM, Severijnen LA, Berry-Kravis EM, Berman RF, Hagerman PJ, Willemsen R, Hagerman RJ, Hukema RK. PMID: 21785977; PMCID: PMC3222079.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansAnimals
    305. FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles. J Mol Diagn. 2011 Sep; 13(5):528-36. Godler DE, Slater HR, Bui QM, Ono M, Gehling F, Francis D, Amor DJ, Hopper JL, Hagerman R, Loesch DZ. PMID: 21723415; PMCID: PMC3157613.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    306. Rare intranuclear inclusions in the brains of 3 older adult males with fragile x syndrome: implications for the spectrum of fragile x-associated disorders. J Neuropathol Exp Neurol. 2011 Jun; 70(6):462-9. Hunsaker MR, Greco CM, Tassone F, Berman RF, Willemsen R, Hagerman RJ, Hagerman PJ. PMID: 21572337; PMCID: PMC3109086.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    307. FMR1 premutation and full mutation molecular mechanisms related to autism. J Neurodev Disord. 2011 Sep; 3(3):211-24. Hagerman R, Au J, Hagerman P. PMID: 21617890; PMCID: PMC3261276.
      View in: PubMed   Mentions: 44     Fields:    
    308. Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome. Hum Mol Genet. 2011 Aug 01; 20(15):3079-92. Napoli E, Ross-Inta C, Wong S, Omanska-Klusek A, Barrow C, Iwahashi C, Garcia-Arocena D, Sakaguchi D, Berry-Kravis E, Hagerman R, Hagerman PJ, Giulivi C. PMID: 21558427; PMCID: PMC3131047.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    309. A Quantitative Assessment of Tremor and Ataxia in Female FMR1 Premutation Carriers Using CATSYS. Curr Gerontol Geriatr Res. 2011; 2011:484713. Narcisa V, Aguilar D, Nguyen DV, Campos L, Brodovsky J, White S, Adams P, Tassone F, Hagerman PJ, Hagerman RJ. PMID: 23008705; PMCID: PMC3114433.
      View in: PubMed   Mentions: 12  
    310. Fragile x syndrome. Curr Genomics. 2011 May; 12(3):216-24. McLennan Y, Polussa J, Tassone F, Hagerman R. PMID: 22043169; PMCID: PMC3137006.
      View in: PubMed   Mentions: 67  
    311. Diffusion tensor imaging in male premutation carriers of the fragile X mental retardation gene. Mov Disord. 2011 Jun; 26(7):1329-36. Hashimoto R, Srivastava S, Tassone F, Hagerman RJ, Rivera SM. PMID: 21484870; PMCID: PMC3119762.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    312. Case report: Dystonia in a fragile X carrier. Mov Disord. 2014 Jun; 29(7):E4-5. Zhang L, Sukharev D, Schneider A, Olichney JM, Seritan A, Hagerman RJ. PMID: 21469199; PMCID: PMC3136610.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    313. A voxel-based morphometry study of grey matter loss in fragile X-associated tremor/ataxia syndrome. Brain. 2011 Mar; 134(Pt 3):863-78. Hashimoto R, Javan AK, Tassone F, Hagerman RJ, Rivera SM. PMID: 21354978; PMCID: PMC3044831.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    314. Clinical phenotypes of a juvenile sibling pair carrying the fragile X premutation. Am J Med Genet A. 2011 Mar; 155A(3):519-25. Basuta K, Narcisa V, Chavez A, Kumar M, Gane L, Hagerman R, Tassone F. PMID: 21344625; PMCID: PMC3568664.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    315. Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome. Mol Autism. 2011 Feb 08; 2(1):2. Greco CM, Navarro CS, Hunsaker MR, Maezawa I, Shuler JF, Tassone F, Delany M, Au JW, Berman RF, Jin LW, Schumann C, Hagerman PJ, Hagerman RJ. PMID: 21303513; PMCID: PMC3045897.
      View in: PubMed   Mentions: 34     Fields:    
    316. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci Transl Med. 2011 Jan 05; 3(64):64ra1. Jacquemont S, Curie A, des Portes V, Torrioli MG, Berry-Kravis E, Hagerman RJ, Ramos FJ, Cornish K, He Y, Paulding C, Neri G, Chen F, Hadjikhani N, Martinet D, Meyer J, Beckmann JS, Delange K, Brun A, Bussy G, Gasparini F, Hilse T, Floesser A, Branson J, Bilbe G, Johns D, Gomez-Mancilla B. PMID: 21209411.
      View in: PubMed   Mentions: 174     Fields:    Translation:HumansCells
    317. Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization. J Neurodev Disord. 2011 Mar; 3(1):57-67. Cordeiro L, Ballinger E, Hagerman R, Hessl D. PMID: 21475730; PMCID: PMC3057014.
      View in: PubMed   Mentions: 150     Fields:    
    318. Assessment of patient and caregiver needs in fragile X-associated tremor/ataxia syndrome by utilizing Q-sort methodology. Aging Ment Health. 2010 Nov; 14(8):1000-7. Gane LW, Iosif AM, Flynn-Wilson L, Venturino M, Hagerman RJ, Seritan AL. PMID: 21069606; PMCID: PMC3189491.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    319. Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome. Neurobiol Aging. 2012 Jun; 33(6):1045-53. Schneider A, Ballinger E, Chavez A, Tassone F, Hagerman RJ, Hessl D. PMID: 20961665; PMCID: PMC3044775.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    320. Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine. J Clin Psychopharmacol. 2010 Oct; 30(5):642-4. Ortigas MC, Bourgeois JA, Schneider A, Olichney J, Nguyen DV, Cogswell JB, Hall DA, Hagerman RJ. PMID: 20841969; PMCID: PMC4022473.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    321. Fragile X and autism: Intertwined at the molecular level leading to targeted treatments. Mol Autism. 2010 Sep 21; 1(1):12. Hagerman R, Hoem G, Hagerman P. PMID: 20858229; PMCID: PMC2954865.
      View in: PubMed   Mentions: 120     Fields:    
    322. Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome. Hum Genet. 2010 Nov; 128(5):539-48. Chonchaiya W, Tassone F, Ashwood P, Hessl D, Schneider A, Campos L, Nguyen DV, Hagerman RJ. PMID: 20809278; PMCID: PMC2955238.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    323. Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures. Am J Intellect Dev Disabil. 2010 Sep; 115(5):433-43. Utari A, Chonchaiya W, Rivera SM, Schneider A, Hagerman RJ, Faradz SM, Ethell IM, Nguyen DV. PMID: 20687826; PMCID: PMC4031088.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    324. Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers. J Clin Psychiatry. 2011 Feb; 72(2):175-82. Bourgeois JA, Seritan AL, Casillas EM, Hessl D, Schneider A, Yang Y, Kaur I, Cogswell JB, Nguyen DV, Hagerman RJ. PMID: 20816038; PMCID: PMC4038118.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    325. Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome. Biochem J. 2010 Aug 01; 429(3):545-52. Ross-Inta C, Omanska-Klusek A, Wong S, Barrow C, Garcia-Arocena D, Iwahashi C, Berry-Kravis E, Hagerman RJ, Hagerman PJ, Giulivi C. PMID: 20513237; PMCID: PMC4011071.
      View in: PubMed   Mentions: 105     Fields:    Translation:HumansCells
    326. Parkinsonism and cognitive decline in a fragile X mosaic male. Mov Disord. 2010 Jul 30; 25(10):1523-4. Hall D, Pickler L, Riley K, Tassone F, Hagerman R. PMID: 20568092; PMCID: PMC4051493.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    327. Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics. 2010 Jul; 7(3):264-74. Wang LW, Berry-Kravis E, Hagerman RJ. PMID: 20643379; PMCID: PMC4084556.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansAnimals
    328. Shifting the paradigm for autism treatments. Neurotherapeutics. 2010 Jul; 7(3):230-1. Hagerman RJ, Hendren RL. PMID: 20643374; PMCID: PMC4043294.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    329. An fMRI study of the prefrontal activity during the performance of a working memory task in premutation carriers of the fragile X mental retardation 1 gene with and without fragile X-associated tremor/ataxia syndrome (FXTAS). J Psychiatr Res. 2011 Jan; 45(1):36-43. Hashimoto R, Backer KC, Tassone F, Hagerman RJ, Rivera SM. PMID: 20537351; PMCID: PMC2978252.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    330. Aging in fragile X syndrome. J Neurodev Disord. 2010 Jun; 2(2):70-76. Utari A, Adams E, Berry-Kravis E, Chavez A, Scaggs F, Ngotran L, Boyd A, Hessl D, Gane LW, Tassone F, Tartaglia N, Leehey MA, Hagerman RJ. PMID: 20585378; PMCID: PMC2882562.
      View in: PubMed   Mentions: 35     Fields:    
    331. Early onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxins. Neurotoxicology. 2010 Aug; 31(4):399-402. Paul R, Pessah IN, Gane L, Ono M, Hagerman PJ, Brunberg JA, Tassone F, Bourgeois JA, Adams PE, Nguyen DV, Hagerman R. PMID: 20466021; PMCID: PMC3918243.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    332. Clinical report: a male with Down syndrome, fragile X syndrome, and autism. J Dev Behav Pediatr. 2010 May; 31(4):333-7. Stevens L, Tartaglia N, Hagerman R, Riley K. PMID: 20453578; PMCID: PMC3740577.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    333. Abnormal N400 word repetition effects in fragile X-associated tremor/ataxia syndrome. Brain. 2010 May; 133(Pt 5):1438-50. Olichney JM, Chan S, Wong LM, Schneider A, Seritan A, Niese A, Yang JC, Laird K, Teichholtz S, Khan S, Tassone F, Hagerman R. PMID: 20410144; PMCID: PMC2859155.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    334. Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome. Clin Genet. 2010 Jul; 78(1):38-46. Chonchaiya W, Nguyen DV, Au J, Campos L, Berry-Kravis EM, Lohse K, Mu Y, Utari A, Hervey C, Wang L, Sorensen P, Cook K, Gane L, Tassone F, Hagerman RJ. PMID: 20497189; PMCID: PMC4031089.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    335. Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers. Am J Med Genet B Neuropsychiatr Genet. 2010 Apr 05; 153B(3):775-85. Adams PE, Adams JS, Nguyen DV, Hessl D, Brunberg JA, Tassone F, Zhang W, Koldewyn K, Rivera SM, Grigsby J, Zhang L, Decarli C, Hagerman PJ, Hagerman RJ. PMID: 19908235; PMCID: PMC2868927.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    336. Fragile X Syndrome and Premutation-Associated Disorders. . 2010 Mar 17; 397-411. Hagerman HR. .
      View in: Publisher Site   Mentions:
    337. Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. Hum Mol Genet. 2010 Apr 15; 19(8):1618-32. Godler DE, Tassone F, Loesch DZ, Taylor AK, Gehling F, Hagerman RJ, Burgess T, Ganesamoorthy D, Hennerich D, Gordon L, Evans A, Choo KH, Slater HR. PMID: 20118148; PMCID: PMC2846165.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    338. Plasma cytokine profiles in Fragile X subjects: is there a role for cytokines in the pathogenesis? Brain Behav Immun. 2010 Aug; 24(6):898-902. Ashwood P, Nguyen DV, Hessl D, Hagerman RJ, Tassone F. PMID: 20102735; PMCID: PMC3626458.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    339. Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Hum Mol Genet. 2010 Jan 01; 19(1):196-208. Chen Y, Tassone F, Berman RF, Hagerman PJ, Hagerman RJ, Willemsen R, Pessah IN. PMID: 19846466; PMCID: PMC2792156.
      View in: PubMed   Mentions: 98     Fields:    Translation:AnimalsCells
    340. Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back. Am J Med Genet A. 2010 Jan; 152A(1):4-24. Rauen KA, Schoyer L, McCormick F, Lin AE, Allanson JE, Stevenson DA, Gripp KW, Neri G, Carey JC, Legius E, Tartaglia M, Schubbert S, Roberts AE, Gelb BD, Shannon K, Gutmann DH, McMahon M, Guerra C, Fagin JA, Yu B, Aoki Y, Neel BG, Balmain A, Drake RR, Nolan GP, Zenker M, Bollag G, Sebolt-Leopold J, Gibbs JB, Silva AJ, Patton EE, Viskochil DH, Kieran MW, Korf BR, Hagerman RJ, Packer RJ, Melese T. PMID: 20014119; PMCID: PMC4051786.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    341. Intergenerational effects of mutations in the fragile X mental retardation 1 gene. Fragile X: A model of X-linked mental retardation and neurodegeneration. . 2010 Jan 1; 3-18. Borodyanskaya BM, Coffey CS, Ono OM, Hagerman HR. .
      View in: Publisher Site   Mentions:
    342. Treatment and Management of FXTAS. . 2010 Jan 1; 137-154. Berry-Kravis BE, Hall HD, Leehey LM, Hagerman HR. .
      View in: Publisher Site   Mentions:
    343. Clinical Neurological Phenotype of FXTAS. . 2010 Jan 1; 1-16. Leehey LM, Berry-Kravis BE, Goetz GC, Hagerman HR. .
      View in: Publisher Site   Mentions:
    344. High-risk fragile x screening in Guatemala: use of a new blood spot polymerase chain reaction technique. Genet Test Mol Biomarkers. 2009 Dec; 13(6):855-9. Yuhas J, Walichiewicz P, Pan R, Zhang W, Casillas EM, Hagerman RJ, Tassone F. PMID: 19810826; PMCID: PMC2935836.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    345. Broad clinical involvement in a family affected by the fragile X premutation. J Dev Behav Pediatr. 2009 Dec; 30(6):544-51. Chonchaiya W, Utari A, Pereira GM, Tassone F, Hessl D, Hagerman RJ. PMID: 19996900; PMCID: PMC2822648.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    346. FRAGILE X SYNDROME AND ASSOCIATED DISORDERS IN ADULTHOOD. CONTINUUM Lifelong Learning in Neurology. 2009 Dec 1; 15(6, Childhood Neurologic Disorders in Adulthood):32-49. Hagerman HR. .
      View in: Publisher Site   Mentions:
    347. Conversion disorder in women with the FMR1 premutation. Am J Med Genet A. 2009 Nov; 149A(11):2501-6. Seritan AL, Schneider A, Olichney JM, Leehey MA, Akins RS, Hagerman RJ. PMID: 19842197; PMCID: PMC2783547.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    348. Fibroblast phenotype in male carriers of FMR1 premutation alleles. Hum Mol Genet. 2010 Jan 15; 19(2):299-312. Garcia-Arocena D, Yang JE, Brouwer JR, Tassone F, Iwahashi C, Berry-Kravis EM, Goetz CG, Sumis AM, Zhou L, Nguyen DV, Campos L, Howell E, Ludwig A, Greco C, Willemsen R, Hagerman RJ, Hagerman PJ. PMID: 19864489; PMCID: PMC2796892.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    349. A voxel-based morphometry comparison of regional gray matter between fragile X syndrome and autism. Psychiatry Res. 2009 Nov 30; 174(2):138-45. Wilson LB, Tregellas JR, Hagerman RJ, Rogers SJ, Rojas DC. PMID: 19853418; PMCID: PMC2783567.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    350. Functional status of men with the fragile X premutation, with and without the tremor/ataxia syndrome (FXTAS). Int J Geriatr Psychiatry. 2009 Oct; 24(10):1101-9. Brega AG, Reynolds A, Bennett RE, Leehey MA, Bounds LS, Cogswell JB, Hagerman RJ, Hagerman PJ, Grigsby J. PMID: 19404994; PMCID: PMC4414034.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    351. Imitation in fragile X syndrome. Implications for autism. Autism. 2009 Nov; 13(6):599-611. Macedoni-Luksic M, Greiss-Hess L, Rogers SJ, Gosar D, Lemons-Chitwood K, Hagerman R. PMID: 19770230; PMCID: PMC4929855.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    352. FMR1 premutation in females diagnosed with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009 Jul; 80(7):812-4. Zhang L, Coffey S, Lua LL, Greco CM, Schafer JA, Brunberg J, Borodyanskaya M, Agius MA, Apperson M, Leehey M, Tartaglia N, Tassone F, Hagerman PJ, Hagerman RJ. PMID: 19531693.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    353. Prepulse inhibition in fragile X syndrome: feasibility, reliability, and implications for treatment. Am J Med Genet B Neuropsychiatr Genet. 2009 Jun 05; 150B(4):545-53. Hessl D, Berry-Kravis E, Cordeiro L, Yuhas J, Ornitz EM, Campbell A, Chruscinski E, Hervey C, Long JM, Hagerman RJ. PMID: 18785205; PMCID: PMC2693303.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    354. A quantitative ELISA assay for the fragile x mental retardation 1 protein. J Mol Diagn. 2009 Jul; 11(4):281-9. Iwahashi C, Tassone F, Hagerman RJ, Yasui D, Parrott G, Nguyen D, Mayeur G, Hagerman PJ. PMID: 19460937; PMCID: PMC2710703.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    355. A review of fragile X premutation disorders: expanding the psychiatric perspective. J Clin Psychiatry. 2009 Jun; 70(6):852-62. Bourgeois JA, Coffey SM, Rivera SM, Hessl D, Gane LW, Tassone F, Greco C, Finucane B, Nelson L, Berry-Kravis E, Grigsby J, Hagerman PJ, Hagerman RJ. PMID: 19422761; PMCID: PMC2705685.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansCells
    356. The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. J Clin Sleep Med. 2009 Apr 15; 5(2):145-50. Wirojanan J, Jacquemont S, Diaz R, Bacalman S, Anders TF, Hagerman RJ, Goodlin-Jones BL. PMID: 19968048; PMCID: PMC2670334.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    357. A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome. J Neurodev Disord. 2009 Mar; 1(1):33-45. Hessl D, Nguyen DV, Green C, Chavez A, Tassone F, Hagerman RJ, Senturk D, Schneider A, Lightbody A, Reiss AL, Hall S. PMID: 19865612; PMCID: PMC2768415.
      View in: PubMed   Mentions: 91     Fields:    
    358. Covariate adjusted correlation analysis with application to FMR1 premutation female carrier data. Biometrics. 2009 Sep; 65(3):781-92. Sentürk D, Nguyen DV, Tassone F, Hagerman RJ, Carroll RJ, Hagerman PJ. PMID: 19173699; PMCID: PMC2748149.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    359. A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J Med Genet. 2009 Apr; 46(4):266-71. Berry-Kravis E, Hessl D, Coffey S, Hervey C, Schneider A, Yuhas J, Hutchison J, Snape M, Tranfaglia M, Nguyen DV, Hagerman R. PMID: 19126569; PMCID: PMC2658751.
      View in: PubMed   Mentions: 178     Fields:    Translation:HumansCTClinical Trials
    360. Advances in the treatment of fragile X syndrome. Pediatrics. 2009 Jan; 123(1):378-90. Hagerman RJ, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A, Kronk R, Delahunty C, Hessl D, Visootsak J, Picker J, Gane L, Tranfaglia M. PMID: 19117905; PMCID: PMC2888470.
      View in: PubMed   Mentions: 270     Fields:    Translation:HumansAnimals
    361. Fragile X: a family of disorders. Adv Pediatr. 2009; 56:165-86. Chonchaiya W, Schneider A, Hagerman RJ. PMID: 19968948; PMCID: PMC2921504.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    362. Fragile X syndrome -- from genes to cognition. Dev Disabil Res Rev. 2009; 15(4):333-42. Schneider A, Hagerman RJ, Hessl D. PMID: 20014363.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    363. Lifespan changes in working memory in fragile X premutation males. Brain Cogn. 2009 Apr; 69(3):551-8. Cornish KM, Kogan CS, Li L, Turk J, Jacquemont S, Hagerman RJ. PMID: 19114290; PMCID: PMC4158922.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    364. Testing for fragile X gene mutations throughout the life span. JAMA. 2008 Nov 26; 300(20):2419-21. Hagerman RJ, Hagerman PJ. PMID: 19033593; PMCID: PMC2766594.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    365. Autism profiles of males with fragile X syndrome. Am J Ment Retard. 2008 Nov; 113(6):427-38. Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I, Tassone F, Hagerman PJ, Herman H, Hagerman RJ. PMID: 19127654; PMCID: PMC2629645.
      View in: PubMed   Mentions: 202     Fields:    Translation:Humans
    366. Dementia in fragile X-associated tremor/ataxia syndrome (FXTAS): comparison with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 05; 147B(7):1138-44. Seritan AL, Nguyen DV, Farias ST, Hinton L, Grigsby J, Bourgeois JA, Hagerman RJ. PMID: 18384046; PMCID: PMC2898561.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    367. Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor/Ataxia syndrome: a controlled study. Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 05; 147B(6):859-72. Kogan CS, Turk J, Hagerman RJ, Cornish KM. PMID: 18165971.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    368. Motor abilities of children diagnosed with fragile X syndrome with and without autism. J Intellect Disabil Res. 2009 Jan; 53(1):11-8. Zingerevich C, Greiss-Hess L, Lemons-Chitwood K, Harris SW, Hessl D, Cook K, Hagerman RJ. PMID: 18771512; PMCID: PMC2614297.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    369. Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis. Arch Neurol. 2008 Aug; 65(8):1114-6. Greco CM, Tassone F, Garcia-Arocena D, Tartaglia N, Coffey SM, Vartanian TK, Brunberg JA, Hagerman PJ, Hagerman RJ. PMID: 18695063; PMCID: PMC3081275.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    370. Secondary medical diagnosis in fragile X syndrome with and without autism spectrum disorder. Am J Med Genet A. 2008 Aug 01; 146A(15):1911-6. García-Nonell C, Ratera ER, Harris S, Hessl D, Ono MY, Tartaglia N, Marvin E, Tassone F, Hagerman RJ. PMID: 18627038; PMCID: PMC4097171.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    371. Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease. Parkinsonism Relat Disord. 2009 Feb; 15(2):156-9. Hall DA, Howard K, Hagerman R, Leehey MA. PMID: 18565783; PMCID: PMC2685192.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    372. Reduced telomere length in older men with premutation alleles of the fragile X mental retardation 1 gene. Am J Med Genet A. 2008 Jun 15; 146A(12):1543-6. Jenkins EC, Tassone F, Ye L, Gu H, Xi M, Velinov M, Brown WT, Hagerman RJ, Hagerman PJ. PMID: 18478592; PMCID: PMC2766597.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    373. A new look at XXYY syndrome: medical and psychological features. Am J Med Genet A. 2008 Jun 15; 146A(12):1509-22. Tartaglia N, Davis S, Hench A, Nimishakavi S, Beauregard R, Reynolds A, Fenton L, Albrecht L, Ross J, Visootsak J, Hansen R, Hagerman R. PMID: 18481271; PMCID: PMC3056496.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    374. Contrast detection in infants with fragile X syndrome. Vision Res. 2008 Jun; 48(13):1471-8. Farzin F, Whitney D, Hagerman RJ, Rivera SM. PMID: 18457856; PMCID: PMC2486371.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    375. Altered hypothalamus-pituitary-adrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome. Psychoneuroendocrinology. 2008 Jul; 33(6):863-73. Brouwer JR, Severijnen E, de Jong FH, Hessl D, Hagerman RJ, Oostra BA, Willemsen R. PMID: 18472227; PMCID: PMC4408208.
      View in: PubMed   Mentions: 43     Fields:    Translation:AnimalsCells
    376. The fragile X continuum: new advances and perspectives. J Intellect Disabil Res. 2008 Jun; 52(Pt 6):469-82. Cornish K, Turk J, Hagerman R. PMID: 18444988.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    377. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A. 2008 Apr 15; 146A(8):1009-16. Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, Bronsky HE, Yuhas J, Borodyanskaya M, Grigsby J, Doerflinger M, Hagerman PJ, Hagerman RJ. PMID: 18348275; PMCID: PMC2888464.
      View in: PubMed   Mentions: 171     Fields:    Translation:HumansCells
    378. A girl with fragile X premutation from sperm donation. Am J Med Genet A. 2008 Apr 01; 146A(7):888-92. Wirojanan J, Angkustsiri K, Tassone F, Gane LW, Hagerman RJ. PMID: 18286596.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    379. Abnormal nerve conduction features in fragile X premutation carriers. Arch Neurol. 2008 Apr; 65(4):495-8. Soontarapornchai K, Maselli R, Fenton-Farrell G, Tassone F, Hagerman PJ, Hessl D, Hagerman RJ. PMID: 18413472; PMCID: PMC2888466.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    380. Two boys with fragile x syndrome and hepatic tumors. J Pediatr Hematol Oncol. 2008 Mar; 30(3):239-41. Wirojanan J, Kraff J, Hawkins DS, Laird C, Gane LW, Angkustsiri K, Tassone F, Hagerman RJ. PMID: 18376289.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    381. A quantitative assessment of tremor and ataxia in FMR1 premutation carriers using CATSYS. Am J Med Genet A. 2008 Mar 01; 146A(5):629-35. Aguilar D, Sigford KE, Soontarapornchai K, Nguyen DV, Adams PE, Yuhas JM, Tassone F, Hagerman PJ, Hagerman RJ. PMID: 18241072.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    382. The primary cognitive deficit among males with fragile X-associated tremor/ataxia syndrome (FXTAS) is a dysexecutive syndrome. J Clin Exp Neuropsychol. 2008 Nov; 30(8):853-69. Brega AG, Goodrich G, Bennett RE, Hessl D, Engle K, Leehey MA, Bounds LS, Paulich MJ, Hagerman RJ, Hagerman PJ, Cogswell JB, Tassone F, Reynolds A, Kooken R, Kenny M, Grigsby J. PMID: 18608667; PMCID: PMC4098148.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    383. Fragile X syndrome with anxiety disorder and exceptional verbal intelligence. Am J Med Genet A. 2008 Feb 01; 146A(3):376-9. Angkustsiri K, Wirojanan J, Deprey LJ, Gane LW, Hagerman RJ. PMID: 18203169.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    384. Reduced Hippocampal Activation During Recall is Associated with Elevated FMR1 mRNA and Psychiatric Symptoms in Men with the Fragile X Premutation. Brain Imaging Behav. 2008 Jan 18; 2(2):105-116. Koldewyn K, Hessl D, Adams J, Tassone F, Hagerman PJ, Hagerman RJ, Rivera SM. PMID: 19430586; PMCID: PMC2678852.
      View in: PubMed   Mentions: 39     Fields:    
    385. Fragile X-associated tremor/ataxia syndrome: an aging face of the fragile X gene. Arch Neurol. 2008 Jan; 65(1):19-25. Amiri K, Hagerman RJ, Hagerman PJ. PMID: 18195136.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    386. Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome. Neuropsychology. 2008 Jan; 22(1):48-60. Grigsby J, Brega AG, Engle K, Leehey MA, Hagerman RJ, Tassone F, Hessl D, Hagerman PJ, Cogswell JB, Bennett RE, Cook K, Hall DA, Bounds LS, Paulich MJ, Reynolds A. PMID: 18211155.
      View in: PubMed   Mentions: 100     Fields:    Translation:HumansCells
    387. Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems. Clin Interv Aging. 2008; 3(2):251-62. Hagerman RJ, Hall DA, Coffey S, Leehey M, Bourgeois J, Gould J, Zhang L, Seritan A, Berry-Kravis E, Olichney J, Miller JW, Fong AL, Carpenter R, Bodine C, Gane LW, Rainin E, Hagerman H, Hagerman PJ. PMID: 18686748; PMCID: PMC2546470.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    388. Age-dependent cognitive changes in carriers of the fragile X syndrome. Cortex. 2008 Jun; 44(6):628-36. Cornish KM, Li L, Kogan CS, Jacquemont S, Turk J, Dalton A, Hagerman RJ, Hagerman PJ. PMID: 18472033.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    389. FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. Neurology. 2008 Apr 15; 70(16 Pt 2):1397-402. Leehey MA, Berry-Kravis E, Goetz CG, Zhang L, Hall DA, Li L, Rice CD, Lara R, Cogswell J, Reynolds A, Gane L, Jacquemont S, Tassone F, Grigsby J, Hagerman RJ, Hagerman PJ. PMID: 18057320; PMCID: PMC2685188.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansCells
    390. Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disord. 2007 Oct 31; 22(14):2018-30, quiz 2140. Berry-Kravis E, Abrams L, Coffey SM, Hall DA, Greco C, Gane LW, Grigsby J, Bourgeois JA, Finucane B, Jacquemont S, Brunberg JA, Zhang L, Lin J, Tassone F, Hagerman PJ, Hagerman RJ, Leehey MA. PMID: 17618523.
      View in: PubMed   Mentions: 142     Fields:    Translation:Humans
    391. An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum Mol Genet. 2007 Dec 15; 16(24):3174-87. Ladd PD, Smith LE, Rabaia NA, Moore JM, Georges SA, Hansen RS, Hagerman RJ, Tassone F, Tapscott SJ, Filippova GN. PMID: 17921506.
      View in: PubMed   Mentions: 158     Fields:    Translation:HumansAnimalsCells
    392. Neuropathy as a presenting feature in fragile X-associated tremor/ataxia syndrome. Am J Med Genet A. 2007 Oct 01; 143A(19):2256-60. Hagerman RJ, Coffey SM, Maselli R, Soontarapornchai K, Brunberg JA, Leehey MA, Zhang L, Gane LW, Fenton-Farrell G, Tassone F, Hagerman PJ. PMID: 17726686.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    393. Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS). Neurology. 2007 Aug 28; 69(9):851-9. Adams JS, Adams PE, Nguyen D, Brunberg JA, Tassone F, Zhang W, Koldewyn K, Rivera SM, Grigsby J, Zhang L, DeCarli C, Hagerman PJ, Hagerman RJ. PMID: 17724287.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansCells
    394. Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome. Gen Hosp Psychiatry. 2007 Jul-Aug; 29(4):349-56. Bourgeois JA, Cogswell JB, Hessl D, Zhang L, Ono MY, Tassone F, Farzin F, Brunberg JA, Grigsby J, Hagerman RJ. PMID: 17591512; PMCID: PMC3991490.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    395. CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS). Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 05; 144B(4):566-9. Tassone F, Adams J, Berry-Kravis EM, Cohen SS, Brusco A, Leehey MA, Li L, Hagerman RJ, Hagerman PJ. PMID: 17427188.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansCells
    396. Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders. J Genet Couns. 2007 Oct; 16(5):593-606. McConkie-Rosell A, Abrams L, Finucane B, Cronister A, Gane LW, Coffey SM, Sherman S, Nelson LM, Berry-Kravis E, Hessl D, Chiu S, Street N, Vatave A, Hagerman RJ. PMID: 17497108.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    397. Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndrome. Mov Disord. 2007 Apr 15; 22(5):645-50. Grigsby J, Brega AG, Leehey MA, Goodrich GK, Jacquemont S, Loesch DZ, Cogswell JB, Epstein J, Wilson R, Jardini T, Gould E, Bennett RE, Hessl D, Cohen S, Cook K, Tassone F, Hagerman PJ, Hagerman RJ. PMID: 17266074.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    398. The Prader-Willi phenotype of fragile X syndrome. J Dev Behav Pediatr. 2007 Apr; 28(2):133-8. Nowicki ST, Tassone F, Ono MY, Ferranti J, Croquette MF, Goodlin-Jones B, Hagerman RJ. PMID: 17435464.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    399. A genetic etiology of pervasive developmental disorder guides treatment. Am J Psychiatry. 2007 Apr; 164(4):575-80. Solomon M, Hessl D, Chiu S, Hagerman R, Hendren R. PMID: 17403969.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    400. Testicular and pituitary inclusion formation in fragile X associated tremor/ataxia syndrome. J Urol. 2007 Apr; 177(4):1434-7. Greco CM, Soontrapornchai K, Wirojanan J, Gould JE, Hagerman PJ, Hagerman RJ. PMID: 17382748.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCells
    401. A preliminary study of screening for risk of autism in children with fragile X syndrome: testing two risk cut-offs for the Checklist for Autism in Toddlers. J Intellect Disabil Res. 2007 Apr; 51(Pt 4):269-76. Scambler DJ, Hepburn SL, Hagerman RJ, Rogers SJ. PMID: 17326808.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    402. Brief report: aggression and stereotypic behavior in males with fragile X syndrome--moderating secondary genes in a "single gene" disorder. J Autism Dev Disord. 2008 Jan; 38(1):184-9. Hessl D, Tassone F, Cordeiro L, Koldewyn K, McCormick C, Green C, Wegelin J, Yuhas J, Hagerman RJ. PMID: 17340199.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    403. Fragile X syndrome vs fragile X-associated tremor/ataxia syndrome. Arch Neurol. 2007 Feb; 64(2):289; author reply 289-90. Leehey MA, Hagerman RJ, Hagerman PJ. PMID: 17296852.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    404. Fragile X-associated tremor/ataxia syndrome--an older face of the fragile X gene. Nat Clin Pract Neurol. 2007 Feb; 3(2):107-12. Hagerman PJ, Hagerman RJ. PMID: 17279084.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    405. Early acceleration of head circumference in children with fragile x syndrome and autism. J Dev Behav Pediatr. 2007 Feb; 28(1):31-5. Chiu S, Wegelin JA, Blank J, Jenkins M, Day J, Hessl D, Tassone F, Hagerman R. PMID: 17353729.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    406. Progression of tremor and ataxia in male carriers of the FMR1 premutation. Mov Disord. 2007 Jan 15; 22(2):203-6. Leehey MA, Berry-Kravis E, Min SJ, Hall DA, Rice CD, Zhang L, Grigsby J, Greco CM, Reynolds A, Lara R, Cogswell J, Jacquemont S, Hessl DR, Tassone F, Hagerman R, Hagerman PJ. PMID: 17133502.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCells
    407. Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. Lancet Neurol. 2007 Jan; 6(1):45-55. Jacquemont S, Hagerman RJ, Hagerman PJ, Leehey MA. PMID: 17166801.
      View in: PubMed   Mentions: 100     Fields:    Translation:Humans
    408. Neuropathic features in fragile X premutation carriers. Am J Med Genet A. 2007 Jan 01; 143A(1):19-26. Berry-Kravis E, Goetz CG, Leehey MA, Hagerman RJ, Zhang L, Li L, Nguyen D, Hall DA, Tartaglia N, Cogswell J, Tassone F, Hagerman PJ. PMID: 17152065.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCellsPHPublic Health
    409. Amygdala dysfunction in men with the fragile X premutation. Brain. 2007 Feb; 130(Pt 2):404-16. Hessl D, Rivera S, Koldewyn K, Cordeiro L, Adams J, Tassone F, Hagerman PJ, Hagerman RJ. PMID: 17166860.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    410. Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X. Neurosci Biobehav Rev. 2007; 31(3):315-26. Loesch DZ, Bui QM, Dissanayake C, Clifford S, Gould E, Bulhak-Paterson D, Tassone F, Taylor AK, Hessl D, Hagerman R, Huggins RM. PMID: 17097142; PMCID: PMC2145511.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    411. The FMR1 premutation and reproduction. Fertil Steril. 2007 Mar; 87(3):456-65. Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL, Nelson LM. PMID: 17074338.
      View in: PubMed   Mentions: 130     Fields:    Translation:HumansCells
    412. Molecular and imaging correlates of the fragile X-associated tremor/ataxia syndrome. Neurology. 2006 Oct 24; 67(8):1426-31. Cohen S, Masyn K, Adams J, Hessl D, Rivera S, Tassone F, Brunberg J, DeCarli C, Zhang L, Cogswell J, Loesch D, Leehey M, Grigsby J, Hagerman PJ, Hagerman R. PMID: 17060569.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    413. Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial. J Child Adolesc Psychopharmacol. 2006 Oct; 16(5):525-40. Berry-Kravis E, Krause SE, Block SS, Guter S, Wuu J, Leurgans S, Decle P, Potanos K, Cook E, Salt J, Maino D, Weinberg D, Lara R, Jardini T, Cogswell J, Johnson SA, Hagerman R. PMID: 17069542.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCellsCTClinical Trials
    414. Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome. Mov Disord. 2006 Oct; 21(10):1741-4. Hall DA, Berry-Kravis E, Hagerman RJ, Hagerman PJ, Rice CD, Leehey MA. PMID: 16773616.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    415. Cognitive impairment in a 65-year-old male with the fragile X-associated tremor-ataxia syndrome (FXTAS). Cogn Behav Neurol. 2006 Sep; 19(3):165-71. Grigsby J, Leehey MA, Jacquemont S, Brunberg JA, Hagerman RJ, Wilson R, Epstein JH, Greco CM, Tassone F, Hagerman PJ. PMID: 16957495.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    416. X inactivation and cellular mosaicism. JAMA. 2006 Aug 23; 296(8):930-1; author reply 931. Hagerman RJ, Hagerman PJ. PMID: 16926349.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    417. Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats. J Med Genet. 2007 Mar; 44(3):200-4. Loesch DZ, Bui QM, Huggins RM, Mitchell RJ, Hagerman RJ, Tassone F. PMID: 16905681; PMCID: PMC2598026.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    418. Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS). J Neurol Sci. 2006 Oct 25; 248(1-2):227-33. Grigsby J, Brega AG, Jacquemont S, Loesch DZ, Leehey MA, Goodrich GK, Hagerman RJ, Epstein J, Wilson R, Cogswell JB, Jardini T, Tassone F, Hagerman PJ. PMID: 16780889.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    419. Size bias of fragile X premutation alleles in late-onset movement disorders. J Med Genet. 2006 Oct; 43(10):804-9. Jacquemont S, Leehey MA, Hagerman RJ, Beckett LA, Hagerman PJ. PMID: 16723388; PMCID: PMC2563171.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    420. Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation. J Dev Behav Pediatr. 2006 Apr; 27(2 Suppl):S137-44. Farzin F, Perry H, Hessl D, Loesch D, Cohen J, Bacalman S, Gane L, Tassone F, Hagerman P, Hagerman R. PMID: 16685180.
      View in: PubMed   Mentions: 168     Fields:    Translation:HumansCells
    421. Prevalence of FMR1 repeat expansions in movement disorders. A systematic review. Neuroepidemiology. 2006; 26(3):151-5. Hall DA, Hagerman RJ, Hagerman PJ, Jacquemont S, Leehey MA. PMID: 16493202.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    422. Lessons from fragile X regarding neurobiology, autism, and neurodegeneration. J Dev Behav Pediatr. 2006 Feb; 27(1):63-74. Hagerman RJ. PMID: 16511373.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansAnimalsCells
    423. Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine. J Neuropsychiatry Clin Neurosci. 2006; 18(2):171-7. Bourgeois JA, Farzin F, Brunberg JA, Tassone F, Hagerman P, Zhang L, Hessl D, Hagerman R. PMID: 16720793.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    424. Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia. J Clin Psychiatry. 2006 Jan; 67(1):87-94. Bacalman S, Farzin F, Bourgeois JA, Cogswell J, Goodlin-Jones BL, Gane LW, Grigsby J, Leehey MA, Tassone F, Hagerman RJ. PMID: 16426093.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    425. Chapter 10 Fragile X Syndrome and Fragile X-Associated Tremor/Ataxia Syndrome. . 2006 Jan 1; (Am. J. Med. Genet.841999):165-174. Hagerman HR, Hagerman HP, Hagerman HP. .
      View in: Publisher Site   Mentions:
    426. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain. 2006 Jan; 129(Pt 1):243-55. Greco CM, Berman RF, Martin RM, Tassone F, Schwartz PH, Chang A, Trapp BD, Iwahashi C, Brunberg J, Grigsby J, Hessl D, Becker EJ, Papazian J, Leehey MA, Hagerman RJ, Hagerman PJ. PMID: 16332642.
      View in: PubMed   Mentions: 257     Fields:    Translation:HumansCells
    427. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 05; 139B(1):115-21. Hessl D, Tassone F, Loesch DZ, Berry-Kravis E, Leehey MA, Gane LW, Barbato I, Rice C, Gould E, Hall DA, Grigsby J, Wegelin JA, Harris S, Lewin F, Weinberg D, Hagerman PJ, Hagerman RJ. PMID: 16184602.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCells
    428. Protein composition of the intranuclear inclusions of FXTAS. Brain. 2006 Jan; 129(Pt 1):256-71. Iwahashi CK, Yasui DH, An HJ, Greco CM, Tassone F, Nannen K, Babineau B, Lebrilla CB, Hagerman RJ, Hagerman PJ. PMID: 16246864.
      View in: PubMed   Mentions: 182     Fields:    Translation:HumansCells
    429. Recent advances in fragile X: a model for autism and neurodegeneration. Curr Opin Psychiatry. 2005 Sep; 18(5):490-6. Hagerman RJ, Ono MY, Hagerman PJ. PMID: 16639106.
      View in: PubMed   Mentions: 52     Fields:    
    430. Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS). Neurology. 2005 Jul 26; 65(2):299-301. Hall DA, Berry-Kravis E, Jacquemont S, Rice CD, Cogswell J, Zhang L, Hagerman RJ, Hagerman PJ, Leehey MA. PMID: 16043804.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    431. No evidence of paternal transmission of fragile X syndrome. Am J Med Genet A. 2005 Jul 01; 136(1):107-8; author reply 109-10. Steinbach D, Steinbach P. PMID: 15887276.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    432. Spastic paraparesis, cerebellar ataxia, and intention tremor: a severe variant of FXTAS? J Med Genet. 2005 Feb; 42(2):e14. Jacquemont S, Orrico A, Galli L, Sahota PK, Brunberg JA, Anichini C, Leehey M, Schaeffer S, Hagerman RJ, Hagerman PJ, Tassone F. PMID: 15689437; PMCID: PMC1735999.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    433. Neural progenitor cells from an adult patient with fragile X syndrome. BMC Med Genet. 2005 Jan 14; 6:2. Schwartz PH, Tassone F, Greco CM, Nethercott HE, Ziaeian B, Hagerman RJ, Hagerman PJ. PMID: 15649335; PMCID: PMC545950.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    434. GRAND ROUNDS: an atypical progressive dementia in a male carrier of the fragile X premutation: an example of fragile X-associated tremor/ataxia syndrome. Appl Neuropsychol. 2005; 12(3):169-78. Mothersead PK, Conrad K, Hagerman RJ, Greco CM, Hessl D, Tassone F. PMID: 16131344.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    435. Autistic spectrum disorder and the fragile X premutation. J Dev Behav Pediatr. 2004 Dec; 25(6):392-8. Goodlin-Jones BL, Tassone F, Gane LW, Hagerman RJ. PMID: 15613987.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansPHPublic Health
    436. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy. Brain. 2004 Dec; 127(Pt 12):2672-81. Moore CJ, Daly EM, Tassone F, Tysoe C, Schmitz N, Ng V, Chitnis X, McGuire P, Suckling J, Davies KE, Hagerman RJ, Hagerman PJ, Murphy KC, Murphy DG. PMID: 15483045.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    437. Annotation: Deconstructing the attention deficit in fragile X syndrome: a developmental neuropsychological approach. J Child Psychol Psychiatry. 2004 Sep; 45(6):1042-53. Cornish KM, Turk J, Wilding J, Sudhalter V, Munir F, Kooy F, Hagerman R. PMID: 15257661.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    438. Paternal transmission of fragile X syndrome. Am J Med Genet A. 2004 Aug 30; 129A(2):184-9. Zeesman S, Zwaigenbaum L, Whelan DT, Hagerman RJ, Tassone F, Taylor SA. PMID: 15316964.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    439. Genetic counseling for families of patients with fragile X syndrome. JAMA. 2004 Jun 23; 291(24):2945; author reply 2945-6. Barrett SK, Drazin T, Rosa D, Kupchik GS. PMID: 15213204.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    440. Linguistic and cognitive functioning and autism symptoms in young children with fragile X syndrome. Am J Ment Retard. 2004 May; 109(3):208-18. Philofsky A, Hepburn SL, Hayes A, Hagerman R, Rogers SJ. PMID: 15072521.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    441. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet. 2004 May; 74(5):1051-6. Hagerman RJ, Leavitt BR, Farzin F, Jacquemont S, Greco CM, Brunberg JA, Tassone F, Hessl D, Harris SW, Zhang L, Jardini T, Gane LW, Ferranti J, Ruiz L, Leehey MA, Grigsby J, Hagerman PJ. PMID: 15065016; PMCID: PMC1181968.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansCells
    442. Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. J Med Genet. 2004 Apr; 41(4):e43. Tassone F, Hagerman RJ, Garcia-Arocena D, Khandjian EW, Greco CM, Hagerman PJ. PMID: 15060119; PMCID: PMC1735735.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansCells
    443. The fragile-X premutation: a maturing perspective. Am J Hum Genet. 2004 May; 74(5):805-16. Hagerman PJ, Hagerman RJ. PMID: 15052536; PMCID: PMC1181976.
      View in: PubMed   Mentions: 182     Fields:    Translation:HumansCells
    444. Aging in individuals with the FMR1 mutation. Am J Ment Retard. 2004 Mar; 109(2):154-64. Jacquemont S, Farzin F, Hall D, Leehey M, Tassone F, Gane L, Zhang L, Grigsby J, Jardini T, Lewin F, Berry-Kravis E, Hagerman PJ, Hagerman RJ. PMID: 15000674; PMCID: PMC3249442.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    445. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA. 2004 Jan 28; 291(4):460-9. Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, Hagerman PJ. PMID: 14747503.
      View in: PubMed   Mentions: 269     Fields:    Translation:HumansCells
    446. Fragile X-associated tremor/ataxia syndrome (FXTAS). Ment Retard Dev Disabil Res Rev. 2004; 10(1):25-30. Hagerman PJ, Hagerman RJ. PMID: 14994285.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    447. A neuropsychological investigation of male premutation carriers of fragile X syndrome. Neuropsychologia. 2004; 42(14):1934-47. Moore CJ, Daly EM, Schmitz N, Tassone F, Tysoe C, Hagerman RJ, Hagerman PJ, Morris RG, Murphy KC, Murphy DG. PMID: 15381024.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    448. Preface: fragile X syndrome: frontiers of understanding gene-brain-behavior relationships. Ment Retard Dev Disabil Res Rev. 2004; 10(1):1-2. Crnic LS, Hagerman R. PMID: 14994281.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    449. Phenotypic variation and FMRP levels in fragile X. Ment Retard Dev Disabil Res Rev. 2004; 10(1):31-41. Loesch DZ, Huggins RM, Hagerman RJ. PMID: 14994286.
      View in: PubMed   Mentions: 140     Fields:    Translation:Humans
    450. Effect of the fragile X status categories and the fragile X mental retardation protein levels on executive functioning in males and females with fragile X. Neuropsychology. 2003 Oct; 17(4):646-657. Loesch DZ, Bui QM, Grigsby J, Butler E, Epstein J, Huggins RM, Taylor AK, Hagerman RJ. PMID: 14599277.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    451. Effect of fragile X status categories and FMRP deficits on cognitive profiles estimated by robust pedigree analysis. Am J Med Genet A. 2003 Sep 15; 122A(1):13-23. Loesch DZ, Huggins RM, Bui QM, Taylor AK, Pratt C, Epstein J, Hagerman RJ. PMID: 12949966.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    452. Genetic and clinical characterization of patients with an interstitial duplication 15q11-q13, emphasizing behavioral phenotype and response to treatment. Am J Med Genet A. 2003 Jun 01; 119A(2):111-20. Thomas JA, Johnson J, Peterson Kraai TL, Wilson R, Tartaglia N, LeRoux J, Beischel L, McGavran L, Hagerman RJ. PMID: 12749048.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    453. Tremor and ataxia in fragile X premutation carriers: blinded videotape study. Ann Neurol. 2003 May; 53(5):616-23. Berry-Kravis E, Lewin F, Wuu J, Leehey M, Hagerman R, Hagerman P, Goetz CG. PMID: 12730995.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    454. Relationship of deficits of FMR1 gene specific protein with physical phenotype of fragile X males and females in pedigrees: a new perspective. Am J Med Genet A. 2003 Apr 15; 118A(2):127-34. Loesch DZ, Huggins RM, Bui QM, Taylor AK, Hagerman RJ. PMID: 12655493.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    455. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet. 2003 Apr; 72(4):869-78. Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, Brunberg JA, Greco C, Des Portes V, Jardini T, Levine R, Berry-Kravis E, Brown WT, Schaeffer S, Kissel J, Tassone F, Hagerman PJ. PMID: 12638084; PMCID: PMC1180350.
      View in: PubMed   Mentions: 307     Fields:    Translation:Humans
    456. The fragile X premutation presenting as essential tremor. Arch Neurol. 2003 Jan; 60(1):117-21. Leehey MA, Munhoz RP, Lang AE, Brunberg JA, Grigsby J, Greco C, Jacquemont S, Tassone F, Lozano AM, Hagerman PJ, Hagerman RJ. PMID: 12533098.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    457. A cerebellar tremor/ataxia syndrome among fragile X premutation carriers. Cytogenet Genome Res. 2003; 100(1-4):206-12. Hagerman PJ, Greco CM, Hagerman RJ. PMID: 14526182.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    458. Effect of the deficits of fragile X mental retardation protein on cognitive status of fragile x males and females assessed by robust pedigree analysis. J Dev Behav Pediatr. 2002 Dec; 23(6):416-23. Loesch DZ, Huggins RM, Bui QM, Epstein JL, Taylor AK, Hagerman RJ. PMID: 12476071.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    459. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA. 2002 Dec; 8(12):1482-8. Primerano B, Tassone F, Hagerman RJ, Hagerman P, Amaldi F, Bagni C. PMID: 12515381; PMCID: PMC1370354.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansCells
    460. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR Am J Neuroradiol. 2002 Nov-Dec; 23(10):1757-66. Brunberg JA, Jacquemont S, Hagerman RJ, Berry-Kravis EM, Grigsby J, Leehey MA, Tassone F, Brown WT, Greco CM, Hagerman PJ. PMID: 12427636; PMCID: PMC8185834.
      View in: PubMed   Mentions: 145     Fields:    Translation:HumansCells
    461. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain. 2002 Aug; 125(Pt 8):1760-71. Greco CM, Hagerman RJ, Tassone F, Chudley AE, Del Bigio MR, Jacquemont S, Leehey M, Hagerman PJ. PMID: 12135967.
      View in: PubMed   Mentions: 236     Fields:    Translation:HumansCells
    462. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry. 2002 Aug; 159(8):1337-46. Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL, Risperidone Disruptive Behavior Study Group. PMID: 12153826.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCTClinical Trials
    463. Tremor/Ataxia syndrome in fragile X carrier males. Movement Disorders. 2002 Jul 1; 17(4):744-745. Leehey LM, Hagerman HR, Landau LW, Grigsby GJ, Tassone TF, Hagerman HP, Hagerman HP. .
      View in: Publisher Site   Mentions:
    464. The fragile X premutation: into the phenotypic fold. Curr Opin Genet Dev. 2002 Jun; 12(3):278-83. Hagerman RJ, Hagerman PJ. PMID: 12076670.
      View in: PubMed   Mentions: 110     Fields:    Translation:Humans
    465. Influence of stimulants on electrodermal studies in Fragile X syndrome. Microsc Res Tech. 2002 May 01; 57(3):168-73. Hagerman RJ, Miller LJ, McGrath-Clarke J, Riley K, Goldson E, Harris SW, Simon J, Church K, Bonnell J, Ognibene TC, McIntosh DN. PMID: 12112453.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    466. The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. J Dev Behav Pediatr. 2001 Dec; 22(6):409-17. Rogers SJ, Wehner DE, Hagerman R. PMID: 11773805.
      View in: PubMed   Mentions: 218     Fields:    Translation:Humans
    467. [Fragile X syndrome: a model of gene-brain-behaviour relationships]. Rev Neurol. 2001 Oct; 33 Suppl 1:S51-7. Hagerman RJ, Hagerman PJ. PMID: 12447820.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    468. Fragile X syndrome: a model of gene-brain-behavior relationships. Mol Genet Metab. 2001 Sep-Oct; 74(1-2):89-97. Hagerman RJ, Hagerman PJ. PMID: 11592806.